Acute Annular Outer Retinopathy

Complex MONDO:0017299 Pathograph 12 Show in embeddings browser Acute disease Eye disorder

Acute annular outer retinopathy (AAOR) is a rare, acutely presenting outer retinal disorder defined by a visible gray-white annular or incomplete peripapillary lesion aligned with visual-field loss. Optical coherence tomography and fundus autofluorescence show injury at the photoreceptor, outer nuclear, Henle fiber, ellipsoid-zone, and retinal pigment epithelium levels. The lesion typically enlarges over the first weeks and then leaves outer retinal atrophy and pigmentary change. Its cause is unknown; immune, infection-associated, and paraneoplastic explanations remain hypotheses. AAOR has historically been placed within the acute zonal occult outer retinopathy (AZOOR) spectrum, while newer work uses acute outer retinopathy (AOR) for a broader range of lesion distributions. Those labels are related but should not be treated as interchangeable.

Ask OpenScientist

Ask a research question about Acute Annular Outer Retinopathy. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

6
Pathophys.
6
Phenotypes
2
Hypotheses
3
Gaps
12
Pathograph
1
Medical Actions
5
Differentials
2
Deep Research
◈

Mechanistic Hypotheses

2
Immune-mediated boundary-injury model
immune_boundary_injury EMERGING
Evidence balance 2 support
The visible gray annular border has been proposed to represent an advancing immune boundary between normal and abnormal outer retina. Antiretinal antibodies have also been reported in AAOR, but neither finding establishes a specific antigen, effector pathway, or causal autoimmune mechanism.
Pathograph links
Putative Immune Boundary Injury -> Acute Photoreceptor and Henle-Layer Injury UNKNOWN A putative immune boundary could advance into previously unaffected outer retina and injure photoreceptor-associated layers.
Show evidence (2 references)
PMID:7872395 SUPPORT Human Clinical
"We speculate that this disorder is part of the spectrum of acute zonal occult outer retinopathy and that the gray border, which separates the normal from the abnormal retina, represents an immune ring phenomenon."
The founding report explicitly labels the immune-ring interpretation as speculation, so it supports a hypothesis rather than an established mechanism.
PMID:18195232 SUPPORT Human Clinical
"Association of antiretinal antibodies in acute annular outer retinopathy."
The publication documents an antibody association, but its cached record contains no abstract capable of establishing causality or specificity.
Viral-infection initiation model
infection_associated_initiation EMERGING
Evidence balance 2 support
An isolated HIV-associated report lists viral infection as one proposed explanation alongside an autoimmune mechanism. It does not determine whether HIV infection or secondary immunosuppression contributed to AAOR.
Pathograph links
Putative Viral-Infection Initiation -> Acute Photoreceptor and Henle-Layer Injury UNKNOWN A proposed viral route could converge on acute outer retinal injury, but whether viral infection contributes at all is unknown.
Show evidence (2 references)
PMID:30455116 SUPPORT Human Clinical
"The aetiology of AAOR remains unknown, although a viral infection or an autoimmune mechanism has been suggested."
The case report describes the proposed routes while explicitly retaining etiologic uncertainty.
PMID:30455116 SUPPORT Human Clinical
"Even so, the precise role played by HIV infection or secondary immunosuppression in the development of the AAOR is not known."
The authors specifically warn that the HIV association does not establish a mechanism.
?

Discussions and Knowledge Gaps

3
Are classic annular AAOR, nonannular acute outer retinopathy, and AZOOR one disease spectrum or overlapping disorders with distinct causes?
CONTROVERSY UNDER DISCUSSION aaor_aor_azoor_nosology
Attached to
disease#Acute Annular Outer Retinopathy
Collapsing the terms obscures differences in visible lesion morphology, cohort composition, frequency estimates, prognosis, and possible etiology.
Show evidence (2 references)
PMID:11078842 SUPPORT Human Clinical
"Acute annular outer retinopathy may be a distinct entity or it may represent a variant of acute zonal occult outer retinopathy retinopathy."
Classic AAOR literature explicitly leaves the AAOR-AZOOR boundary open.
PMID:40436146 SUPPORT Human Clinical
"Although distinct patterns of lesion distribution were observed, their consistent features on multimodal imaging support their inclusion within a unified disease spectrum termed AOR."
The newer multicenter cohort proposes a broader unifying AOR spectrum.
What initiates AAOR, and are antiretinal antibodies, viral associations, immune dysregulation, and malignancy causal, secondary, or coincidental?
KNOWLEDGE GAP OPEN aaor_upstream_cause
Attached to
pathophysiology#Putative Immune Boundary Injury pathophysiology#Putative Viral-Infection Initiation
The founding report did not determine a cause, and the HIV-associated report did not determine the role of HIV infection or secondary immunosuppression. These observations leave the proposed upstream routes unresolved.
Show evidence (2 references)
PMID:7872395 SUPPORT Human Clinical
"The cause of this disorder, which affects primarily the outer retina, was not determined."
The founding report explicitly states that the cause was undetermined.
PMID:30455116 SUPPORT Human Clinical
"Even so, the precise role played by HIV infection or secondary immunosuppression in the development of the AAOR is not known."
The infection-associated report preserves causal uncertainty.
Can any early intervention prevent lesion enlargement or outer retinal atrophy in AAOR, and which patients should be selected for treatment trials?
KNOWLEDGE GAP OPEN aaor_disease_modifying_treatment
Attached to
pathophysiology#Acute Photoreceptor and Henle-Layer Injury pathophysiology#Outer Retinal Atrophy treatments#Serial multimodal retinal monitoring
Treatment reports are uncontrolled, phenotypes and diagnostic labels vary, and the largest observational series found no intervention that appeared to halt lesion enlargement or complete atrophy.
Show evidence (1 reference)
PMID:40436146 SUPPORT Human Clinical
"None of the therapeutic interventions appeared effective in halting the progression to complete outer retinal atrophy or preventing lesion enlargement."
This directly defines the current therapeutic evidence gap.
⚙

Pathophysiology

6
Putative Immune Boundary Injury
A hypothesized immune process at the advancing gray-white border could initiate regional outer retinal injury. The initiating antigen, immune effector, and direction of causality remain unknown.
Immune-mediated boundary-injury model
retina UBERON:0000966 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in retina (UBERON:0000966). UBERON:0000966 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Acute Photoreceptor and Henle-Layer Injury A putative immune boundary could advance into previously unaffected outer retina and injure photoreceptor-associated layers. Immune-mediated boundary-injury model
Show evidence (1 reference)
PMID:7872395 SUPPORT Human Clinical
"the gray border, which separates the normal from the abnormal retina, represents an immune ring phenomenon"
This is a disease-specific but explicitly speculative observation.
Putative Viral-Infection Initiation
Viral infection has been suggested as a possible initiator, but the available HIV-associated case report establishes neither that association nor a mechanism.
Viral-infection initiation model
retina UBERON:0000966 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in retina (UBERON:0000966). UBERON:0000966 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Acute Photoreceptor and Henle-Layer Injury A proposed viral route could converge on acute outer retinal injury, but whether viral infection contributes at all is unknown. Viral-infection initiation model
Show evidence (1 reference)
PMID:30455116 SUPPORT Human Clinical
"The aetiology of AAOR remains unknown, although a viral infection or an autoimmune mechanism has been suggested."
This supports only an alternative etiologic model.
Acute Photoreceptor and Henle-Layer Injury
Acute yellow-gray outer retinal lesions correspond on OCT to early photoreceptor disruption and angular hyperreflectivity involving the Henle fiber layer. This structural injury is the best-supported early disease event.
photoreceptor cell CL:0000210 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves photoreceptor cell (CL:0000210). CL:0000210 is a cell type from the Cell Ontology.
photoreceptor cell maintenance GO:0045494 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal photoreceptor cell maintenance (GO:0045494). GO:0045494 is a biological process from the Gene Ontology. ⚠ ABNORMAL
photoreceptor layer of retina UBERON:0001787 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in photoreceptor layer of retina (UBERON:0001787). UBERON:0001787 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Ellipsoid Zone and Outer Nuclear Layer Disruption Acute photoreceptor-associated hyperreflectivity and disruption of the ellipsoid and external limiting membrane bands occur within annular outer retinal lesions. Their direct causal ordering is not established.
Photopsia Dysfunction of acutely injured photoreceptors is associated with flashing visual phenomena.
Show evidence (1 reference)
PMID:40436146 SUPPORT Human Clinical
"Acute outer retinopathy is characterized by early photoreceptor disruption, evidenced by ASHH on OCT, leading to rapid outer retinal atrophy and subsequent degeneration of the retinal pigment epithelium within the damaged zones."
The multicenter longitudinal series identifies the earliest structural abnormality and its subsequent trajectory.
Ellipsoid Zone and Outer Nuclear Layer Disruption
Within the annular lesion, the ellipsoid zone and external limiting membrane become indistinct or absent, and the outer nuclear layer becomes hyperreflective acutely and thinned during progression.
photoreceptor cell CL:0000210 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves photoreceptor cell (CL:0000210). CL:0000210 is a cell type from the Cell Ontology.
visual perception GO:0007601 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased visual perception (GO:0007601). GO:0007601 is a biological process from the Gene Ontology. ↓ DECREASED
photoreceptor layer of retina UBERON:0001787 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in photoreceptor layer of retina (UBERON:0001787). UBERON:0001787 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Outer Retinal Atrophy Outer retinal atrophy later occupies areas where the acute white ring was visible, but the observations do not isolate a direct causal step from ellipsoid-zone or outer-nuclear-layer disruption.
Scotoma The annular outer retinal lesion and localized scotoma are spatially associated; direct causation by this particular structural node is not separately tested.
Visual Field Defect Annular outer retinal injury co-localizes with a corresponding region of visual-field loss, without proof of a direct causal step from the named structural abnormalities.
Blurred Vision Macular involvement is associated with reduced visual acuity, and blurred vision is reported in the broader AOR cohort. A direct mechanism linking the named structural changes to blurred vision was not quantified.
Show evidence (3 references)
PMID:25383859 SUPPORT Human Clinical
"We found hyperreflectivity in the outer nuclear layer and the Henle fiber layer along with marked atrophy of the outer retina within the white ring."
OCT directly maps the white ring to outer nuclear, Henle-layer, and outer retinal structural injury.
PMID:30079710 SUPPORT Human Clinical
"OCT demonstrated an indistinct ellipsoid zone, disruption of external limiting membrane, and bulging of the retinal pigment epithelium in the annular lesions."
This directly supports ellipsoid-zone and external-limiting-membrane abnormalities within an annular lesion.
PMID:40446848 SUPPORT Human Clinical
"During APS, advancement of peripapillary annular band was noted in all eyes, accompanied by absent ellipsoid zone, increased choroidal thickness (ChT) and thinned outer nuclear layer (ONL) within the affected area."
The AAOR stage series directly documents absent ellipsoid zone and outer nuclear layer thinning during the progressive stage.
Outer Retinal Atrophy
Damaged photoreceptor and outer nuclear layers undergo rapid regional atrophy. Foveal sparing or focal photoreceptor restoration can preserve acuity, but atrophy usually persists elsewhere within the involved zone.
photoreceptor cell CL:0000210 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves photoreceptor cell (CL:0000210). CL:0000210 is a cell type from the Cell Ontology.
photoreceptor layer of retina UBERON:0001787 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in photoreceptor layer of retina (UBERON:0001787). UBERON:0001787 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Secondary Retinal Pigment Epithelium Degeneration Retinal pigment epithelium degeneration follows photoreceptor and outer retinal loss within the damaged zones.
Retinal Atrophy The chronic outer-retinal tissue loss is observed clinically as regional retinal atrophy with pigmentary change.
Show evidence (1 reference)
PMID:40436146 SUPPORT Human Clinical
"Over time, affected areas progressed to outer retinal atrophy with pigmentary changes."
The larger observational cohort establishes outer retinal atrophy as the typical chronic tissue outcome.
Secondary Retinal Pigment Epithelium Degeneration
The damaged region later develops RPE atrophy, depigmentation, pigment migration, and mixed hyperautofluorescent and hypoautofluorescent changes.
retinal pigment epithelial cell CL:0002586 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves retinal pigment epithelial cell (CL:0002586). CL:0002586 is a cell type from the Cell Ontology.
pigmented layer of retina UBERON:0001782 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in pigmented layer of retina (UBERON:0001782). UBERON:0001782 is an anatomical location from the Uberon multi-species anatomy ontology.
Show evidence (3 references)
PMID:36434575 SUPPORT Human Clinical
"Fundus autofluorescence correlated with structural alterations seen on SD-OCT and showed both presumed active hyperautofluorescent zones with patchy hypoautofluorescent zones of atrophy and a classic annular hyperautofluorescent border."
FAF and OCT jointly document active-border and atrophic RPE-associated changes.
PMID:40446848 SUPPORT Human Clinical
"During AS, affected area became depigmented with scattered pigmentation, exhibiting hyper-AF or mixed AF."
The AAOR stage series directly documents depigmentation and later pigmentary and autofluorescence changes.
PMID:7872395 SUPPORT Human Clinical
"The patient experienced a short period of concentric enlargement of the scotoma and narrowing of the retinal vessels within the ring, followed by stabilization of the scotoma and slow progressive depigmentation and intraretinal migration of the retinal pigment epithelium within the zone of visual loss."
Longitudinal observation in the founding case directly supports later RPE depigmentation and intraretinal migration.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Acute Annular Outer Retinopathy Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

6
Eye 4
Photopsia HP:0030786 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Photopsia (HP:0030786). HP:0030786 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:36434575 SUPPORT Human Clinical
"The patient presented with photopsias and visual loss approximately 3 weeks prior to a diagnosis of invasive ductal breast carcinoma."
A classic annular case directly documents photopsia at presentation.
Context-specific annotations (1)
23-patient expanded AOR-spectrum cohort VERY_FREQUENT
Photopsia was reported by 87% of patients. This estimate comes from the broader AOR spectrum and is not asserted as an exact frequency for classic annular-only AAOR.
Show evidence (1 reference)
PMID:40436146 SUPPORT Human Clinical
"Presenting symptoms included photopsia (87%), blurred vision (57%), and scotoma (57%)."
The cohort directly quantifies photopsia in the expanded spectrum.
Blurred Vision HP:0000622 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Blurred vision (HP:0000622). HP:0000622 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:40436146 SUPPORT Human Clinical
"Presenting symptoms included photopsia (87%), blurred vision (57%), and scotoma (57%)."
This directly supports blurred vision as a presenting symptom.
Context-specific annotations (1)
23-patient expanded AOR-spectrum cohort FREQUENT
Blurred vision was reported by 57% of patients in the broader AOR-spectrum cohort.
Show evidence (1 reference)
PMID:40436146 SUPPORT Human Clinical
"Presenting symptoms included photopsia (87%), blurred vision (57%), and scotoma (57%)."
The cohort directly quantifies blurred vision in the expanded spectrum.
Visual Field Defect HP:0001123 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Visual field defect (HP:0001123). HP:0001123 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:11078842 SUPPORT Human Clinical
"Four healthy patients developed the acute onset of visual field loss associated with a localized, white annular outer retinopathy."
The four-case series directly links acute visual-field loss to the annular retinal lesion.
Abnormal Electroretinogram HP:0000512 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Abnormal electroretinogram (HP:0000512). HP:0000512 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:19847620 SUPPORT Human Clinical
"Predominant loss of rod-mediated electroretinogram response in a case of acute annular outer retinopathy."
This is limited to a publication-title assertion from a single case.
Other 2
Scotoma HP:0000575 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Scotoma (HP:0000575). HP:0000575 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:7872395 SUPPORT Human Clinical
"A 23-year-old man developed a rapid-onset, large, dense scotoma that was associated with a peculiar gray intraretinal ring corresponding to the edge of the scotoma and normal fluorescein angiographic findings."
The classic case directly supports both acute onset and lesion-field correspondence.
Context-specific annotations (1)
23-patient expanded AOR-spectrum cohort FREQUENT
Scotoma was reported by 57% of patients in the broader AOR-spectrum cohort.
Show evidence (1 reference)
PMID:40436146 SUPPORT Human Clinical
"Presenting symptoms included photopsia (87%), blurred vision (57%), and scotoma (57%)."
The cohort directly quantifies scotoma in the expanded spectrum.
Retinal Atrophy HP:0001105 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Retinal atrophy (HP:0001105). HP:0001105 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:40436146 SUPPORT Human Clinical
"Over time, affected areas progressed to outer retinal atrophy with pigmentary changes."
This directly supports retinal atrophy as the later structural phenotype.
💊

Medical Actions

1
Serial multimodal retinal monitoring
Category: Monitoring Action: ophthalmologist evaluationNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is ophthalmologist evaluation, annotated with Eye Examination (NCIT:C38060). NCIT:C38060 is a clinical intervention from the NCI Thesaurus. Ontology label: Eye Examination NCIT:C38060
In an expanded AOR cohort, the interventions used did not appear to prevent lesion enlargement or complete outer-retinal atrophy. Serial ophthalmologic examination and imaging can document the evolving retinal changes.
Show evidence (2 references)
PMID:40436146 SUPPORT Human Clinical
"None of the therapeutic interventions appeared effective in halting the progression to complete outer retinal atrophy or preventing lesion enlargement."
The broader AOR cohort found no apparent benefit from its observed interventions; this is not a controlled efficacy estimate for classic annular-only AAOR.
PMID:25383859 SUPPORT Human Clinical
"We used Spectralis OCT to image the transient intraretinal whitening that is initially seen in this disorder, and the OCT changes during follow-up."
This AAOR case directly supports longitudinal OCT documentation of the evolving structural changes.
🔬

Diagnosis

6
Multimodal retinal evaluation
Diagnosis is clinical and imaging-based. Ophthalmoscopy, OCT, FAF, visual field testing, and selected electrophysiology can be interpreted together with assessment for relevant mimics.
ophthalmologist evaluation NCIT:C38060 NCI Thesaurus (NCIT)
Results: Concordance among an acute outer retinal lesion, field defect, OCT layer disruption, and FAF abnormality supports AAOR.
Show evidence (1 reference)
PMID:40436146 SUPPORT Human Clinical
"Specific multimodal imaging signatures of AOR were identified, including findings from ophthalmoscopy, fundus autofluorescence (FAF), fluorescein angiography, indocyanine green angiography (ICGA), and OCT."
The largest longitudinal series supports a multimodal diagnostic approach.
Optical coherence tomography
OCT localizes reported AAOR abnormalities, including acute Henle-layer and outer-nuclear-layer hyperreflectivity, ellipsoid-zone or external-limiting-membrane disruption in affected lesions, and outer-retinal atrophy on follow-up. These observations do not establish one invariant structural sequence.
optical coherence tomography NCIT:C20828 NCI Thesaurus (NCIT)
Results: ASHH, ellipsoid-zone loss, external limiting membrane disruption, outer nuclear layer change, and later outer retinal atrophy support AAOR and map its extent.
Show evidence (2 references)
PMID:25383859 SUPPORT Human Clinical
"We found hyperreflectivity in the outer nuclear layer and the Henle fiber layer along with marked atrophy of the outer retina within the white ring."
The first acute-phase spectral-domain OCT report provides direct layer-level diagnostic evidence.
PMID:30079710 SUPPORT Human Clinical
"OCT demonstrated an indistinct ellipsoid zone, disruption of external limiting membrane, and bulging of the retinal pigment epithelium in the annular lesions."
This case supports the ellipsoid-zone and external-limiting-membrane findings without establishing their temporal order.
Fundus autofluorescence imaging
FAF delineates active hyperautofluorescent borders and later atrophic hypoautofluorescent zones in classic annular AAOR.
fundus autofluorescence imaging NCIT:C162465 NCI Thesaurus (NCIT)
Results: A hyperautofluorescent active margin with internal patchy atrophy is compatible with AAOR.
Show evidence (1 reference)
PMID:36434575 SUPPORT Human Clinical
"Fundus autofluorescence correlated with structural alterations seen on SD-OCT and showed both presumed active hyperautofluorescent zones with patchy hypoautofluorescent zones of atrophy and a classic annular hyperautofluorescent border."
The case directly supports FAF for mapping the active border and atrophic interior.
Visual field testing (perimetry)
Formal perimetry maps the symptomatic scotoma against the annular retinal lesion.
visual field testing (perimetry) NCIT:C156778 NCI Thesaurus (NCIT)
Results: A localized field defect aligned with the visible and imaged lesion supports AAOR.
Show evidence (1 reference)
PMID:11078842 SUPPORT Human Clinical
"Four healthy patients developed the acute onset of visual field loss associated with a localized, white annular outer retinopathy."
The case series establishes lesion-field concordance as a central feature.
Electroretinography
A predominant reduction in rod-mediated response has been described in one AAOR case. The title-only cached evidence does not establish a disease-specific ERG signature or diagnostic performance.
electroretinogram procedure NCIT:C101217 NCI Thesaurus (NCIT)
Results: An abnormal ERG supports outer retinal dysfunction but is not independently diagnostic of AAOR.
Show evidence (1 reference)
PMID:19847620 SUPPORT Human Clinical
"Predominant loss of rod-mediated electroretinogram response in a case of acute annular outer retinopathy."
Only the title-level single-case assertion is available in the cached source, so the diagnostic claim is deliberately narrow.
Fluorescein and indocyanine green angiography
Fluorescein angiography and ICGA were mostly unremarkable in the expanded AOR cohort and can be interpreted as contextual multimodal findings.
fluorescein angiography NCIT:C190541 NCI Thesaurus (NCIT)
Results: Mostly unremarkable angiography despite a visible outer retinal lesion is compatible with the reported AOR imaging pattern.
Show evidence (1 reference)
PMID:40436146 SUPPORT Human Clinical
"Fluorescein angiography and ICGA findings were mostly unremarkable."
The multicenter cohort directly describes the typical angiographic result.
🩻

Imaging Findings

4
Angular Henle-layer hyperreflectivity and early photoreceptor disruption
Acute yellow-gray lesions correspond to the angular sign of Henle fiber layer hyperreflectivity on OCT, marking early photoreceptor injury at the advancing lesion.
Oct Segmental
Angular Henle-layer hyperreflectivity with photoreceptor disruption photoreceptor layer of retina UBERON:0001787 Uberon multi-species anatomy ontology (UBERON)
Show evidence (1 reference)
PMID:40436146 SUPPORT Human Clinical
"On ophthalmoscopy, AOR was acutely characterized by yellow-grayish outer retinal lesions corresponding to hyperautofluorescent changes on FAF and the angular sign of Henle fiber layer hyperreflectivity (ASHH) on OCT."
The multicenter series directly maps the acute fundus lesion to FAF and OCT signatures.
Ellipsoid-zone loss and outer nuclear layer thinning
Within advancing AAOR, OCT shows an absent ellipsoid zone and a thinned outer nuclear layer. External limiting membrane disruption and RPE bulging have also been documented within annular lesions.
Oct Segmental
Ellipsoid-zone loss and outer nuclear layer thinning photoreceptor layer of retina UBERON:0001787 Uberon multi-species anatomy ontology (UBERON)
Show evidence (2 references)
PMID:40446848 SUPPORT Human Clinical
"During APS, advancement of peripapillary annular band was noted in all eyes, accompanied by absent ellipsoid zone, increased choroidal thickness (ChT) and thinned outer nuclear layer (ONL) within the affected area."
This directly describes OCT abnormalities during the progressive stage.
PMID:30079710 SUPPORT Human Clinical
"OCT demonstrated an indistinct ellipsoid zone, disruption of external limiting membrane, and bulging of the retinal pigment epithelium in the annular lesions."
A multimodal AAOR case independently documents the layer-specific OCT abnormalities.
Outer retinal atrophy within the former annular lesion
Follow-up OCT demonstrates marked and progressive outer retinal atrophy in areas occupied by the acute white ring, while foveal photoreceptors can recover in selected eyes.
Oct Segmental
Outer retinal atrophy within the former annular lesion retina UBERON:0000966 Uberon multi-species anatomy ontology (UBERON) Retinal atrophy HP:0001105 Human Phenotype Ontology (HP)
Show evidence (1 reference)
PMID:25383859 SUPPORT Human Clinical
"We documented restoration of foveal photoreceptors, which corresponded with visual recovery. We also noted progressive atrophy in areas where the white ring was previously visible."
Serial OCT directly documents both region-specific atrophy and possible focal foveal recovery.
Annular peripapillary autofluorescence abnormality
Classic AAOR can show a peripapillary annular hyperautofluorescent border around active outer retinal injury, with patchy hypoautofluorescence or mixed autofluorescence developing in atrophic areas inside the border.
Other Segmental
Annular peripapillary fundus autofluorescence abnormality retina UBERON:0000966 Uberon multi-species anatomy ontology (UBERON)
Fundus autofluorescence is represented with modality OTHER because the current imaging-modality enum has no dedicated FAF value.
Show evidence (2 references)
PMID:40436146 SUPPORT Human Clinical
"Fundus autofluorescence imaging revealed ring-like hyperautofluorescent lesions surrounding the optic disc in 18% of eyes."
This documents the annular pattern within the broader AOR cohort without assigning its cohort frequency to classic AAOR.
PMID:36434575 SUPPORT Human Clinical
"Fundus autofluorescence correlated with structural alterations seen on SD-OCT and showed both presumed active hyperautofluorescent zones with patchy hypoautofluorescent zones of atrophy and a classic annular hyperautofluorescent border."
A classic AAOR case directly documents the active annular border and internal atrophic FAF changes.
📈

Progression

4
Acutely progressive stage
Duration: 1 to 3 weeks
The peripapillary annular band advances during the early stage, with loss of the ellipsoid zone, thinning of the outer nuclear layer, and increased choroidal thickness within the affected region.
Show evidence (2 references)
PMID:40446848 SUPPORT Human Clinical
"The clinical course was subdivided acutely progressive stage (APS), stationary stage (SS) and atrophic stage (AS) (1-3 weeks, 3 weeks to 3 months and >3 months, respectively)."
The AAOR case series defines the early progressive interval and the two later stages.
PMID:40446848 SUPPORT Human Clinical
"During APS, advancement of peripapillary annular band was noted in all eyes, accompanied by absent ellipsoid zone, increased choroidal thickness (ChT) and thinned outer nuclear layer (ONL) within the affected area."
This directly describes structural change while the annular lesion is advancing.
Stationary stage
Duration: Approximately 3 weeks to 3 months
Lesion size usually stabilizes after the initial weeks. The visible annular band can fade even though damaged retina remains abnormal and proceeds toward atrophy.
Show evidence (2 references)
PMID:40436146 SUPPORT Human Clinical
"Lesion progression primarily occurred within the initial weeks after presentation and stabilized in size beyond this period in the majority of eyes."
The multicenter AOR-spectrum cohort supports early enlargement followed by size stabilization in most eyes.
PMID:40446848 SUPPORT Human Clinical
"During SS, annular band disappeared on fundus photograph with improved ONL with improved ONL."
The AAOR stage series directly supports fading of the visible annular band during the stationary interval.
Atrophic stage
Duration: More than 3 months after onset
Previously involved retina develops outer retinal atrophy, depigmentation, and scattered pigmentary change. Structural recovery can occur at the fovea in some eyes, but atrophy progresses in areas formerly occupied by the white ring.
Show evidence (3 references)
PMID:40436146 SUPPORT Human Clinical
"Over time, affected areas progressed to outer retinal atrophy with pigmentary changes."
This directly establishes the chronic structural outcome in the larger AOR-spectrum cohort.
PMID:40446848 SUPPORT Human Clinical
"During AS, affected area became depigmented with scattered pigmentation, exhibiting hyper-AF or mixed AF."
The AAOR stage series directly describes pigmentary and autofluorescence changes after three months.
PMID:25383859 SUPPORT Human Clinical
"We documented restoration of foveal photoreceptors, which corresponded with visual recovery. We also noted progressive atrophy in areas where the white ring was previously visible."
Longitudinal OCT in a classic AAOR case shows that focal foveal recovery and persistent regional atrophy can coexist.
Long-term visual outcome
Central acuity is strongly influenced by whether the macula is involved. Eyes with macular sparing can retain normal acuity, whereas macular involvement can leave severe persistent impairment.
Show evidence (1 reference)
PMID:40446848 SUPPORT Human Clinical
"Seven eyes of 5 patients showed no macular involvement with best corrected visual acuity (BCVA) of 20/20, while 5 eyes of 5 patients showed macular involvement with poorer BCVA of HM-20/400 at the last visit."
This case series directly links macular involvement to worse final visual acuity.
🔀

Differential Diagnoses

5

Conditions with similar clinical presentations that must be differentiated from Acute Annular Outer Retinopathy:

Acute zonal occult outer retinopathy Not Yet Curated MONDO:0017298
Overlapping Features AZOOR shares acute photopsia, scotoma, and outer retinal dysfunction with AAOR. Whether AAOR is a distinct disorder or a visible annular variant of AZOOR remains unresolved.
Distinguishing Features
  • AAOR has a clinically visible gray-white annular or incomplete peripapillary border aligned with the field defect.
  • The broader AZOOR diagnosis includes occult or zonal disease without the classic annular lesion.
Show evidence (1 reference)
PMID:11078842 SUPPORT Human Clinical
"Acute annular outer retinopathy may be a distinct entity or it may represent a variant of acute zonal occult outer retinopathy retinopathy."
The AAOR case series explicitly records the unresolved disease boundary.
Autoimmune and paraneoplastic retinopathy MONDO:0100014
Overlapping Features Autoimmune or paraneoplastic outer retinal disease is a relevant alternative when malignancy and a corresponding autoreactive-antibody profile are present. Antiretinal antibodies have also been reported in AAOR, so antibody positivity alone does not settle the distinction.
Distinguishing Features
  • A characteristic advancing annular lesion supports AAOR morphology.
  • A cancer-associated syndrome with a corresponding autoantibody profile supports a paraneoplastic alternative.
Show evidence (2 references)
PMID:24428923 SUPPORT Human Clinical
"Specific cross-reacting autoimmunity against recoverin or collapsin response mediator protein (CRMP)-5 is known to cause cancer-associated retinopathy or paraneoplastic optic neuropathy, respectively."
This supports the existence of an antibody-associated paraneoplastic outer retinal alternative, but it is not a direct AAOR comparison study.
PMID:18195232 SUPPORT Human Clinical
"Association of antiretinal antibodies in acute annular outer retinopathy."
The title documents antibody association in AAOR, but the cached record has no abstract with which to assess specificity.
Syphilitic outer retinitis
Overlapping Features Syphilitic outer retinitis can closely resemble an AZOOR-like outer retinal disorder on FAF and OCT and is important because antimicrobial treatment can improve the structural and visual abnormalities.
Distinguishing Features
  • Positive syphilis testing and compatible inflammatory findings favor infection.
  • Ellipsoid-zone and FAF abnormalities can improve after parenteral penicillin.
Show evidence (2 references)
PMID:28297032 SUPPORT Human Clinical
"SOR can present similarly to AZOOR on UWFFAF and should be highly suspected in cases presenting like AZOOR."
The series explicitly identifies syphilitic outer retinitis as an AZOOR-like mimic.
PMID:28297032 SUPPORT Human Clinical
"Treatment with parenteral penicillin led to improvement of outer retinopathy, visual acuity, and symptoms."
The same series directly supports clinical improvement after antimicrobial treatment.
Optic neuritis MONDO:0005885
Overlapping Features Sudden visual loss, subtle initial fundus findings, and field defects can lead to an erroneous optic-neuritis diagnosis when the primary lesion is in the outer retina.
Distinguishing Features
  • AAOR shows photoreceptor-layer and FAF abnormalities aligned with the field defect.
  • Objective evidence localizing disease to the optic nerve favors optic neuritis.
Show evidence (1 reference)
PMID:37685787 SUPPORT Human Clinical
"Multimodal retinal imaging is essential in detecting these conditions and in their differential diagnosis."
The review supports multimodal retinal imaging to distinguish acute retinal disorders from optic neuritis.
Retinitis pigmentosa and other inherited retinal dystrophies MONDO:0019200
Overlapping Features Inherited retinal dystrophies can produce field loss, photoreceptor atrophy, pigment migration, and abnormal ERG, particularly after AAOR has entered its atrophic phase.
Distinguishing Features
  • AAOR has acute onset and a focal advancing lesion rather than a longstanding hereditary course.
  • Family history, bilateral symmetric progression, and molecular testing favor an inherited dystrophy.
Show evidence (1 reference)
PMID:38454854 SUPPORT Human Clinical
"This condition, distinct from genetic disorders like retinitis pigmentosa, lacks a hereditary basis and exhibits unique fundus changes and imaging features indicative of outer retinal dysfunction."
The source directly contrasts AZOOR with inherited retinitis pigmentosa; applying that distinction to AAOR is an AZOOR-spectrum extrapolation.
{ }

Source YAML

click to show 
name: Acute Annular Outer Retinopathy
creation_date: '2026-05-04T19:32:38Z'
description: >-
  Acute annular outer retinopathy (AAOR) is a rare, acutely presenting outer
  retinal disorder defined by a visible gray-white annular or incomplete
  peripapillary lesion aligned with visual-field loss. Optical coherence
  tomography and fundus autofluorescence show injury at the photoreceptor,
  outer nuclear, Henle fiber, ellipsoid-zone, and retinal pigment epithelium
  levels. The lesion typically enlarges over the first weeks and then leaves
  outer retinal atrophy and pigmentary change. Its cause is unknown; immune,
  infection-associated, and paraneoplastic explanations remain hypotheses.
  AAOR has historically been placed within the acute zonal occult outer
  retinopathy (AZOOR) spectrum, while newer work uses acute outer retinopathy
  (AOR) for a broader range of lesion distributions. Those labels are related
  but should not be treated as interchangeable.
category: Complex
disease_term:
  preferred_term: acute annular outer retinopathy
  term:
    id: MONDO:0017299
    label: acute annular outer retinopathy
synonyms:
- AAOR
parents:
- Acute disease
- Eye disorder
progression:
- phase: Acutely progressive stage
  duration: 1 to 3 weeks
  notes: >-
    The peripapillary annular band advances during the early stage, with loss of
    the ellipsoid zone, thinning of the outer nuclear layer, and increased
    choroidal thickness within the affected region.
  evidence:
  - reference: PMID:40446848
    reference_title: "Acute annular outer retinopathy: initial insights into clinical course variations with multimodal imaging."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The clinical course was subdivided acutely progressive stage (APS),
      stationary stage (SS) and atrophic stage (AS) (1-3 weeks, 3 weeks to 3
      months and >3 months, respectively).
    explanation: >-
      The AAOR case series defines the early progressive interval and the two
      later stages.
  - reference: PMID:40446848
    reference_title: "Acute annular outer retinopathy: initial insights into clinical course variations with multimodal imaging."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "During APS, advancement of peripapillary annular band was noted in all eyes, accompanied by absent ellipsoid zone, increased choroidal thickness (ChT) and thinned outer nuclear layer (ONL) within the affected area."  # codespell:ignore-line
    explanation: >-
      This directly describes structural change while the annular lesion is
      advancing.
- phase: Stationary stage
  duration: Approximately 3 weeks to 3 months
  notes: >-
    Lesion size usually stabilizes after the initial weeks. The visible annular
    band can fade even though damaged retina remains abnormal and proceeds
    toward atrophy.
  evidence:
  - reference: PMID:40436146
    reference_title: "Clinical and Multimodal Imaging of Acute Outer Retinopathy: Expanding the Spectrum of Acute Annular Outer Retinopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Lesion progression primarily occurred within the initial weeks after
      presentation and stabilized in size beyond this period in the majority of
      eyes.
    explanation: >-
      The multicenter AOR-spectrum cohort supports early enlargement followed
      by size stabilization in most eyes.
  - reference: PMID:40446848
    reference_title: "Acute annular outer retinopathy: initial insights into clinical course variations with multimodal imaging."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "During SS, annular band disappeared on fundus photograph with improved ONL with improved ONL."  # codespell:ignore-line
    explanation: >-
      The AAOR stage series directly supports fading of the visible annular band
      during the stationary interval.
- phase: Atrophic stage
  duration: More than 3 months after onset
  notes: >-
    Previously involved retina develops outer retinal atrophy, depigmentation,
    and scattered pigmentary change. Structural recovery can occur at the fovea
    in some eyes, but atrophy progresses in areas formerly occupied by the
    white ring.
  evidence:
  - reference: PMID:40436146
    reference_title: "Clinical and Multimodal Imaging of Acute Outer Retinopathy: Expanding the Spectrum of Acute Annular Outer Retinopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Over time, affected areas progressed to outer retinal atrophy with
      pigmentary changes.
    explanation: >-
      This directly establishes the chronic structural outcome in the larger
      AOR-spectrum cohort.
  - reference: PMID:40446848
    reference_title: "Acute annular outer retinopathy: initial insights into clinical course variations with multimodal imaging."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      During AS, affected area became depigmented with scattered pigmentation,
      exhibiting hyper-AF or mixed AF.
    explanation: >-
      The AAOR stage series directly describes pigmentary and autofluorescence
      changes after three months.
  - reference: PMID:25383859
    reference_title: New insights into acute annular outer retinopathy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We documented restoration of foveal photoreceptors, which corresponded
      with visual recovery. We also noted progressive atrophy in areas where the
      white ring was previously visible.
    explanation: >-
      Longitudinal OCT in a classic AAOR case shows that focal foveal recovery
      and persistent regional atrophy can coexist.
- phase: Long-term visual outcome
  notes: >-
    Central acuity is strongly influenced by whether the macula is involved.
    Eyes with macular sparing can retain normal acuity, whereas macular
    involvement can leave severe persistent impairment.
  evidence:
  - reference: PMID:40446848
    reference_title: "Acute annular outer retinopathy: initial insights into clinical course variations with multimodal imaging."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Seven eyes of 5 patients showed no macular involvement with best corrected
      visual acuity (BCVA) of 20/20, while 5 eyes of 5 patients showed macular
      involvement with poorer BCVA of HM-20/400 at the last visit.
    explanation: >-
      This case series directly links macular involvement to worse final visual
      acuity.
mechanistic_hypotheses:
- hypothesis_group_id: immune_boundary_injury
  hypothesis_label: Immune-mediated boundary-injury model
  status: EMERGING
  description: >-
    The visible gray annular border has been proposed to represent an advancing
    immune boundary between normal and abnormal outer retina. Antiretinal
    antibodies have also been reported in AAOR, but neither finding establishes
    a specific antigen, effector pathway, or causal autoimmune mechanism.
  evidence:
  - reference: PMID:7872395
    reference_title: Acute annular outer retinopathy as a variant of acute zonal occult outer retinopathy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We speculate that this disorder is part of the spectrum of acute zonal
      occult outer retinopathy and that the gray border, which separates the
      normal from the abnormal retina, represents an immune ring phenomenon.
    explanation: >-
      The founding report explicitly labels the immune-ring interpretation as
      speculation, so it supports a hypothesis rather than an established
      mechanism.
  - reference: PMID:18195232
    reference_title: Association of antiretinal antibodies in acute annular outer retinopathy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Association of antiretinal antibodies in acute annular outer retinopathy.
    explanation: >-
      The publication documents an antibody association, but its cached record
      contains no abstract capable of establishing causality or specificity.
- hypothesis_group_id: infection_associated_initiation
  hypothesis_label: Viral-infection initiation model
  status: EMERGING
  description: >-
    An isolated HIV-associated report lists viral infection as one proposed
    explanation alongside an autoimmune mechanism. It does not determine whether
    HIV infection or secondary immunosuppression contributed to AAOR.
  evidence:
  - reference: PMID:30455116
    reference_title: Acute annular outer retinopathy associated with human immunodeficiency virus.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The aetiology of AAOR remains unknown, although a viral infection or an
      autoimmune mechanism has been suggested.
    explanation: >-
      The case report describes the proposed routes while explicitly retaining
      etiologic uncertainty.
  - reference: PMID:30455116
    reference_title: Acute annular outer retinopathy associated with human immunodeficiency virus.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Even so, the precise role played by HIV infection or secondary
      immunosuppression in the development of the AAOR is not known.
    explanation: >-
      The authors specifically warn that the HIV association does not establish
      a mechanism.
pathophysiology:
- name: Putative Immune Boundary Injury
  description: >-
    A hypothesized immune process at the advancing gray-white border could
    initiate regional outer retinal injury. The initiating antigen, immune
    effector, and direction of causality remain unknown.
  locations:
  - preferred_term: retina
    term:
      id: UBERON:0000966
      label: retina
  evidence:
  - reference: PMID:7872395
    reference_title: Acute annular outer retinopathy as a variant of acute zonal occult outer retinopathy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      the gray border, which separates the normal from the abnormal retina,
      represents an immune ring phenomenon
    explanation: >-
      This is a disease-specific but explicitly speculative observation.
  downstream:
  - target: Acute Photoreceptor and Henle-Layer Injury
    description: >-
      A putative immune boundary could advance into previously unaffected outer
      retina and injure photoreceptor-associated layers.
    causal_link_type: UNKNOWN
    hypothesis_groups:
    - immune_boundary_injury
    evidence:
    - reference: PMID:7872395
      reference_title: Acute annular outer retinopathy as a variant of acute zonal occult outer retinopathy.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        We speculate that this disorder is part of the spectrum of acute zonal
        occult outer retinopathy and that the gray border, which separates the
        normal from the abnormal retina, represents an immune ring phenomenon.
      explanation: >-
        The edge preserves the original uncertainty rather than asserting a
        direct immune mechanism.
- name: Putative Viral-Infection Initiation
  description: >-
    Viral infection has been suggested as a possible initiator, but the
    available HIV-associated case report establishes neither that association
    nor a mechanism.
  locations:
  - preferred_term: retina
    term:
      id: UBERON:0000966
      label: retina
  evidence:
  - reference: PMID:30455116
    reference_title: Acute annular outer retinopathy associated with human immunodeficiency virus.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The aetiology of AAOR remains unknown, although a viral infection or an
      autoimmune mechanism has been suggested.
    explanation: >-
      This supports only an alternative etiologic model.
  downstream:
  - target: Acute Photoreceptor and Henle-Layer Injury
    description: >-
      A proposed viral route could converge on acute outer retinal injury, but
      whether viral infection contributes at all is unknown.
    causal_link_type: UNKNOWN
    hypothesis_groups:
    - infection_associated_initiation
    evidence:
    - reference: PMID:30455116
      reference_title: Acute annular outer retinopathy associated with human immunodeficiency virus.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Even so, the precise role played by HIV infection or secondary
        immunosuppression in the development of the AAOR is not known.
      explanation: >-
        The unknown link type and partial support encode the uncertainty stated
        by the report.
- name: Acute Photoreceptor and Henle-Layer Injury
  description: >-
    Acute yellow-gray outer retinal lesions correspond on OCT to early
    photoreceptor disruption and angular hyperreflectivity involving the Henle
    fiber layer. This structural injury is the best-supported early disease
    event.
  locations:
  - preferred_term: photoreceptor layer of retina
    term:
      id: UBERON:0001787
      label: photoreceptor layer of retina
  cell_types:
  - preferred_term: photoreceptor cell
    term:
      id: CL:0000210
      label: photoreceptor cell
  biological_processes:
  - preferred_term: photoreceptor cell maintenance
    modifier: ABNORMAL
    term:
      id: GO:0045494
      label: photoreceptor cell maintenance
  evidence:
  - reference: PMID:40436146
    reference_title: "Clinical and Multimodal Imaging of Acute Outer Retinopathy: Expanding the Spectrum of Acute Annular Outer Retinopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Acute outer retinopathy is characterized by early photoreceptor
      disruption, evidenced by ASHH on OCT, leading to rapid outer retinal
      atrophy and subsequent degeneration of the retinal pigment epithelium
      within the damaged zones.
    explanation: >-
      The multicenter longitudinal series identifies the earliest structural
      abnormality and its subsequent trajectory.
  downstream:
  - target: Ellipsoid Zone and Outer Nuclear Layer Disruption
    description: >-
      Acute photoreceptor-associated hyperreflectivity and disruption of the
      ellipsoid and external limiting membrane bands occur within annular outer
      retinal lesions. Their direct causal ordering is not established.
    causal_link_type: UNKNOWN
    evidence:
    - reference: PMID:30079710
      reference_title: "[Multimodal Imaging of a Case of Acute Annular Outer Retinopathy]."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        OCT demonstrated an indistinct ellipsoid zone, disruption of external
        limiting membrane, and bulging of the retinal pigment epithelium in the
        annular lesions.
      explanation: >-
        Cross-sectional multimodal imaging co-localizes outer retinal
        abnormalities but does not establish that one directly causes another.
  - target: Photopsia
    description: >-
      Dysfunction of acutely injured photoreceptors is associated with flashing
      visual phenomena.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:40436146
      reference_title: "Clinical and Multimodal Imaging of Acute Outer Retinopathy: Expanding the Spectrum of Acute Annular Outer Retinopathy."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Presenting symptoms included photopsia (87%), blurred vision (57%), and
        scotoma (57%).
      explanation: >-
        The cohort establishes photopsia as a common concomitant of acute outer
        retinal injury, while the precise signaling pathway remains unresolved.
- name: Ellipsoid Zone and Outer Nuclear Layer Disruption
  description: >-
    Within the annular lesion, the ellipsoid zone and external limiting membrane
    become indistinct or absent, and the outer nuclear layer becomes
    hyperreflective acutely and thinned during progression.
  locations:
  - preferred_term: photoreceptor layer of retina
    term:
      id: UBERON:0001787
      label: photoreceptor layer of retina
  cell_types:
  - preferred_term: photoreceptor cell
    term:
      id: CL:0000210
      label: photoreceptor cell
  biological_processes:
  - preferred_term: visual perception
    modifier: DECREASED
    term:
      id: GO:0007601
      label: visual perception
  evidence:
  - reference: PMID:25383859
    reference_title: New insights into acute annular outer retinopathy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We found hyperreflectivity in the outer nuclear layer and the Henle fiber
      layer along with marked atrophy of the outer retina within the white ring.
    explanation: >-
      OCT directly maps the white ring to outer nuclear, Henle-layer, and outer
      retinal structural injury.
  - reference: PMID:30079710
    reference_title: "[Multimodal Imaging of a Case of Acute Annular Outer Retinopathy]."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      OCT demonstrated an indistinct ellipsoid zone, disruption of external
      limiting membrane, and bulging of the retinal pigment epithelium in the
      annular lesions.
    explanation: >-
      This directly supports ellipsoid-zone and external-limiting-membrane
      abnormalities within an annular lesion.
  - reference: PMID:40446848
    reference_title: "Acute annular outer retinopathy: initial insights into clinical course variations with multimodal imaging."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "During APS, advancement of peripapillary annular band was noted in all eyes, accompanied by absent ellipsoid zone, increased choroidal thickness (ChT) and thinned outer nuclear layer (ONL) within the affected area."  # codespell:ignore-line
    explanation: >-
      The AAOR stage series directly documents absent ellipsoid zone and outer
      nuclear layer thinning during the progressive stage.
  downstream:
  - target: Outer Retinal Atrophy
    description: >-
      Outer retinal atrophy later occupies areas where the acute white ring was
      visible, but the observations do not isolate a direct causal step from
      ellipsoid-zone or outer-nuclear-layer disruption.
    causal_link_type: UNKNOWN
    evidence:
    - reference: PMID:25383859
      reference_title: New insights into acute annular outer retinopathy.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        We also noted progressive atrophy in areas where the white ring was
        previously visible.
      explanation: >-
        Longitudinal OCT establishes temporal and spatial association, not a
        direct causal mechanism.
  - target: Scotoma
    description: >-
      The annular outer retinal lesion and localized scotoma are spatially
      associated; direct causation by this particular structural node is not
      separately tested.
    causal_link_type: UNKNOWN
    evidence:
    - reference: PMID:7872395
      reference_title: Acute annular outer retinopathy as a variant of acute zonal occult outer retinopathy.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        A 23-year-old man developed a rapid-onset, large, dense scotoma that was
        associated with a peculiar gray intraretinal ring corresponding to the
        edge of the scotoma and normal fluorescein angiographic findings.
      explanation: >-
        The founding observation spatially co-localizes the lesion edge and the
        scotoma.
  - target: Visual Field Defect
    description: >-
      Annular outer retinal injury co-localizes with a corresponding region of
      visual-field loss, without proof of a direct causal step from the named
      structural abnormalities.
    causal_link_type: UNKNOWN
    evidence:
    - reference: PMID:36434575
      reference_title: "Acute annular outer retinopathy preceded by invasive ductal breast carcinoma: a case report."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        We identified RPE atrophy with nodular hyperreflectivity and loss of
        ellipsoid layer within the white annular ring with corresponding visual
        field loss.
      explanation: >-
        Structural loss and the functional field deficit co-localized within the
        same annular zone.
  - target: Blurred Vision
    description: >-
      Macular involvement is associated with reduced visual acuity, and blurred
      vision is reported in the broader AOR cohort. A direct mechanism linking
      the named structural changes to blurred vision was not quantified.
    causal_link_type: UNKNOWN
    evidence:
    - reference: PMID:40446848
      reference_title: "Acute annular outer retinopathy: initial insights into clinical course variations with multimodal imaging."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Seven eyes of 5 patients showed no macular involvement with best
        corrected visual acuity (BCVA) of 20/20, while 5 eyes of 5 patients
        showed macular involvement with poorer BCVA of HM-20/400 at the last
        visit.
      explanation: >-
        The macular-involvement comparison supports association with reduced
        central acuity, not a direct mechanism for blurred vision.
    - reference: PMID:40436146
      reference_title: "Clinical and Multimodal Imaging of Acute Outer Retinopathy: Expanding the Spectrum of Acute Annular Outer Retinopathy."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Presenting symptoms included photopsia (87%), blurred vision (57%), and
        scotoma (57%).
      explanation: >-
        The broader AOR cohort documents blurred vision as a concomitant symptom
        but does not establish the proposed structural mechanism.
- name: Outer Retinal Atrophy
  description: >-
    Damaged photoreceptor and outer nuclear layers undergo rapid regional
    atrophy. Foveal sparing or focal photoreceptor restoration can preserve
    acuity, but atrophy usually persists elsewhere within the involved zone.
  locations:
  - preferred_term: photoreceptor layer of retina
    term:
      id: UBERON:0001787
      label: photoreceptor layer of retina
  cell_types:
  - preferred_term: photoreceptor cell
    term:
      id: CL:0000210
      label: photoreceptor cell
  evidence:
  - reference: PMID:40436146
    reference_title: "Clinical and Multimodal Imaging of Acute Outer Retinopathy: Expanding the Spectrum of Acute Annular Outer Retinopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Over time, affected areas progressed to outer retinal atrophy with
      pigmentary changes.
    explanation: >-
      The larger observational cohort establishes outer retinal atrophy as the
      typical chronic tissue outcome.
  downstream:
  - target: Secondary Retinal Pigment Epithelium Degeneration
    description: >-
      Retinal pigment epithelium degeneration follows photoreceptor and outer
      retinal loss within the damaged zones.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:40436146
      reference_title: "Clinical and Multimodal Imaging of Acute Outer Retinopathy: Expanding the Spectrum of Acute Annular Outer Retinopathy."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Acute outer retinopathy is characterized by early photoreceptor
        disruption, evidenced by ASHH on OCT, leading to rapid outer retinal
        atrophy and subsequent degeneration of the retinal pigment epithelium
        within the damaged zones.
      explanation: >-
        The conclusion orders the observations temporally but does not establish
        a direct causal mechanism between outer-retinal atrophy and RPE change.
  - target: Retinal Atrophy
    description: >-
      The chronic outer-retinal tissue loss is observed clinically as regional
      retinal atrophy with pigmentary change.
    causal_link_type: UNKNOWN
    evidence:
    - reference: PMID:40436146
      reference_title: "Clinical and Multimodal Imaging of Acute Outer Retinopathy: Expanding the Spectrum of Acute Annular Outer Retinopathy."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Over time, affected areas progressed to outer retinal atrophy with
        pigmentary changes.
      explanation: >-
        This directly connects the pathophysiology node to the recorded retinal
        atrophy phenotype without asserting a molecular mechanism.
- name: Secondary Retinal Pigment Epithelium Degeneration
  description: >-
    The damaged region later develops RPE atrophy, depigmentation, pigment
    migration, and mixed hyperautofluorescent and hypoautofluorescent changes.
  locations:
  - preferred_term: pigmented layer of retina
    term:
      id: UBERON:0001782
      label: pigmented layer of retina
  cell_types:
  - preferred_term: retinal pigment epithelial cell
    term:
      id: CL:0002586
      label: retinal pigment epithelial cell
  evidence:
  - reference: PMID:36434575
    reference_title: "Acute annular outer retinopathy preceded by invasive ductal breast carcinoma: a case report."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Fundus autofluorescence correlated with structural alterations seen on
      SD-OCT and showed both presumed active hyperautofluorescent zones with
      patchy hypoautofluorescent zones of atrophy and a classic annular
      hyperautofluorescent border.
    explanation: >-
      FAF and OCT jointly document active-border and atrophic RPE-associated
      changes.
  - reference: PMID:40446848
    reference_title: "Acute annular outer retinopathy: initial insights into clinical course variations with multimodal imaging."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      During AS, affected area became depigmented with scattered pigmentation,
      exhibiting hyper-AF or mixed AF.
    explanation: >-
      The AAOR stage series directly documents depigmentation and later
      pigmentary and autofluorescence changes.
  - reference: PMID:7872395
    reference_title: Acute annular outer retinopathy as a variant of acute zonal occult outer retinopathy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The patient experienced a short period of concentric enlargement of the
      scotoma and narrowing of the retinal vessels within the ring, followed by
      stabilization of the scotoma and slow progressive depigmentation and
      intraretinal migration of the retinal pigment epithelium within the zone of
      visual loss.
    explanation: >-
      Longitudinal observation in the founding case directly supports later RPE
      depigmentation and intraretinal migration.
phenotypes:
- category: Ophthalmologic
  name: Photopsia
  description: >-
    Flashing-light phenomena are a common acute symptom in the expanded
    AOR-spectrum cohort and accompany outer retinal photoreceptor injury.
  phenotype_term:
    preferred_term: Photopsia
    term:
      id: HP:0030786
      label: Photopsia
  phenotype_contexts:
  - population: 23-patient expanded AOR-spectrum cohort
    frequency: VERY_FREQUENT
    notes: >-
      Photopsia was reported by 87% of patients. This estimate comes from the
      broader AOR spectrum and is not asserted as an exact frequency for classic
      annular-only AAOR.
    evidence:
    - reference: PMID:40436146
      reference_title: "Clinical and Multimodal Imaging of Acute Outer Retinopathy: Expanding the Spectrum of Acute Annular Outer Retinopathy."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Presenting symptoms included photopsia (87%), blurred vision (57%), and
        scotoma (57%).
      explanation: >-
        The cohort directly quantifies photopsia in the expanded spectrum.
  evidence:
  - reference: PMID:36434575
    reference_title: "Acute annular outer retinopathy preceded by invasive ductal breast carcinoma: a case report."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The patient presented with photopsias and visual loss approximately 3
      weeks prior to a diagnosis of invasive ductal breast carcinoma.
    explanation: >-
      A classic annular case directly documents photopsia at presentation.
- category: Ophthalmologic
  name: Scotoma
  description: >-
    A dense localized scotoma can arise rapidly and correspond spatially to the
    advancing annular lesion.
  phenotype_term:
    preferred_term: Scotoma
    term:
      id: HP:0000575
      label: Scotoma
  phenotype_contexts:
  - population: 23-patient expanded AOR-spectrum cohort
    frequency: FREQUENT
    notes: >-
      Scotoma was reported by 57% of patients in the broader AOR-spectrum
      cohort.
    evidence:
    - reference: PMID:40436146
      reference_title: "Clinical and Multimodal Imaging of Acute Outer Retinopathy: Expanding the Spectrum of Acute Annular Outer Retinopathy."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Presenting symptoms included photopsia (87%), blurred vision (57%), and
        scotoma (57%).
      explanation: >-
        The cohort directly quantifies scotoma in the expanded spectrum.
  evidence:
  - reference: PMID:7872395
    reference_title: Acute annular outer retinopathy as a variant of acute zonal occult outer retinopathy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A 23-year-old man developed a rapid-onset, large, dense scotoma that was
      associated with a peculiar gray intraretinal ring corresponding to the
      edge of the scotoma and normal fluorescein angiographic findings.
    explanation: >-
      The classic case directly supports both acute onset and lesion-field
      correspondence.
- category: Ophthalmologic
  name: Blurred Vision
  description: >-
    Blurred vision is common in the broader AOR spectrum; severity depends in
    part on whether outer retinal injury reaches the macula.
  phenotype_term:
    preferred_term: Blurred vision
    term:
      id: HP:0000622
      label: Blurred vision
  phenotype_contexts:
  - population: 23-patient expanded AOR-spectrum cohort
    frequency: FREQUENT
    notes: >-
      Blurred vision was reported by 57% of patients in the broader AOR-spectrum
      cohort.
    evidence:
    - reference: PMID:40436146
      reference_title: "Clinical and Multimodal Imaging of Acute Outer Retinopathy: Expanding the Spectrum of Acute Annular Outer Retinopathy."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Presenting symptoms included photopsia (87%), blurred vision (57%), and
        scotoma (57%).
      explanation: >-
        The cohort directly quantifies blurred vision in the expanded spectrum.
  evidence:
  - reference: PMID:40436146
    reference_title: "Clinical and Multimodal Imaging of Acute Outer Retinopathy: Expanding the Spectrum of Acute Annular Outer Retinopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Presenting symptoms included photopsia (87%), blurred vision (57%), and
      scotoma (57%).
    explanation: >-
      This directly supports blurred vision as a presenting symptom.
- category: Ophthalmologic
  name: Visual Field Defect
  description: >-
    Acute field loss corresponds to the localized annular outer retinal lesion
    and may persist after lesion expansion stops.
  phenotype_term:
    preferred_term: Visual field defect
    term:
      id: HP:0001123
      label: Visual field defect
  evidence:
  - reference: PMID:11078842
    reference_title: "Acute annular outer retinopathy: report of four cases."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Four healthy patients developed the acute onset of visual field loss
      associated with a localized, white annular outer retinopathy.
    explanation: >-
      The four-case series directly links acute visual-field loss to the annular
      retinal lesion.
- category: Ophthalmologic
  name: Retinal Atrophy
  description: >-
    Previously involved outer retina becomes atrophic and develops pigmentary
    change after the acute lesion has stabilized.
  phenotype_term:
    preferred_term: Retinal atrophy
    term:
      id: HP:0001105
      label: Retinal atrophy
  evidence:
  - reference: PMID:40436146
    reference_title: "Clinical and Multimodal Imaging of Acute Outer Retinopathy: Expanding the Spectrum of Acute Annular Outer Retinopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Over time, affected areas progressed to outer retinal atrophy with
      pigmentary changes.
    explanation: >-
      This directly supports retinal atrophy as the later structural phenotype.
- category: Ophthalmologic
  name: Abnormal Electroretinogram
  description: >-
    Electroretinography can demonstrate outer retinal dysfunction; one AAOR
    report specifically described predominant loss of the rod-mediated
    response. The available cached record supports only a single-case finding,
    not a characteristic frequency or universal ERG pattern.
  phenotype_term:
    preferred_term: Abnormal electroretinogram
    term:
      id: HP:0000512
      label: Abnormal electroretinogram
  reports_on:
  - target: Acute Photoreceptor and Henle-Layer Injury
    relationship: READOUT_OF
    endpoint_context: DIAGNOSTIC
    interpretation: >-
      Reduced rod-mediated response provides functional evidence of outer
      retinal photoreceptor dysfunction in an individual AAOR case.
    evidence:
    - reference: PMID:19847620
      reference_title: Predominant loss of rod-mediated electroretinogram response in a case of acute annular outer retinopathy.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: Predominant loss of rod-mediated electroretinogram response in a case of acute annular outer retinopathy.
      explanation: >-
        The title documents the case finding, but the cached record has no
        abstract from which to infer broader diagnostic performance.
  evidence:
  - reference: PMID:19847620
    reference_title: Predominant loss of rod-mediated electroretinogram response in a case of acute annular outer retinopathy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Predominant loss of rod-mediated electroretinogram response in a case of acute annular outer retinopathy.
    explanation: >-
      This is limited to a publication-title assertion from a single case.
imaging_findings:
- name: Angular Henle-layer hyperreflectivity and early photoreceptor disruption
  modality: OCT
  imaging_finding_term:
    preferred_term: Angular Henle-layer hyperreflectivity with photoreceptor disruption
  located_in:
    preferred_term: photoreceptor layer of retina
    term:
      id: UBERON:0001787
      label: photoreceptor layer of retina
  spatial_extent: SEGMENTAL
  description: >-
    Acute yellow-gray lesions correspond to the angular sign of Henle fiber
    layer hyperreflectivity on OCT, marking early photoreceptor injury at the
    advancing lesion.
  evidence:
  - reference: PMID:40436146
    reference_title: "Clinical and Multimodal Imaging of Acute Outer Retinopathy: Expanding the Spectrum of Acute Annular Outer Retinopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      On ophthalmoscopy, AOR was acutely characterized by yellow-grayish outer
      retinal lesions corresponding to hyperautofluorescent changes on FAF and
      the angular sign of Henle fiber layer hyperreflectivity (ASHH) on OCT.
    explanation: >-
      The multicenter series directly maps the acute fundus lesion to FAF and
      OCT signatures.
- name: Ellipsoid-zone loss and outer nuclear layer thinning
  modality: OCT
  imaging_finding_term:
    preferred_term: Ellipsoid-zone loss and outer nuclear layer thinning
  located_in:
    preferred_term: photoreceptor layer of retina
    term:
      id: UBERON:0001787
      label: photoreceptor layer of retina
  spatial_extent: SEGMENTAL
  description: >-
    Within advancing AAOR, OCT shows an absent ellipsoid zone and a thinned outer
    nuclear layer. External limiting membrane disruption and RPE bulging have
    also been documented within annular lesions.
  evidence:
  - reference: PMID:40446848
    reference_title: "Acute annular outer retinopathy: initial insights into clinical course variations with multimodal imaging."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "During APS, advancement of peripapillary annular band was noted in all eyes, accompanied by absent ellipsoid zone, increased choroidal thickness (ChT) and thinned outer nuclear layer (ONL) within the affected area."  # codespell:ignore-line
    explanation: >-
      This directly describes OCT abnormalities during the progressive stage.
  - reference: PMID:30079710
    reference_title: "[Multimodal Imaging of a Case of Acute Annular Outer Retinopathy]."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      OCT demonstrated an indistinct ellipsoid zone, disruption of external
      limiting membrane, and bulging of the retinal pigment epithelium in the
      annular lesions.
    explanation: >-
      A multimodal AAOR case independently documents the layer-specific OCT
      abnormalities.
- name: Outer retinal atrophy within the former annular lesion
  modality: OCT
  imaging_finding_term:
    preferred_term: Outer retinal atrophy within the former annular lesion
  located_in:
    preferred_term: retina
    term:
      id: UBERON:0000966
      label: retina
  spatial_extent: SEGMENTAL
  phenotype_term:
    preferred_term: Retinal atrophy
    term:
      id: HP:0001105
      label: Retinal atrophy
  description: >-
    Follow-up OCT demonstrates marked and progressive outer retinal atrophy in
    areas occupied by the acute white ring, while foveal photoreceptors can
    recover in selected eyes.
  evidence:
  - reference: PMID:25383859
    reference_title: New insights into acute annular outer retinopathy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We documented restoration of foveal photoreceptors, which corresponded
      with visual recovery. We also noted progressive atrophy in areas where the
      white ring was previously visible.
    explanation: >-
      Serial OCT directly documents both region-specific atrophy and possible
      focal foveal recovery.
- name: Annular peripapillary autofluorescence abnormality
  modality: OTHER
  imaging_finding_term:
    preferred_term: Annular peripapillary fundus autofluorescence abnormality
  located_in:
    preferred_term: retina
    term:
      id: UBERON:0000966
      label: retina
  spatial_extent: SEGMENTAL
  description: >-
    Classic AAOR can show a peripapillary annular hyperautofluorescent border
    around active outer retinal injury, with patchy hypoautofluorescence or
    mixed autofluorescence developing in atrophic areas inside the border.
  notes: >-
    Fundus autofluorescence is represented with modality OTHER because the
    current imaging-modality enum has no dedicated FAF value.
  evidence:
  - reference: PMID:40436146
    reference_title: "Clinical and Multimodal Imaging of Acute Outer Retinopathy: Expanding the Spectrum of Acute Annular Outer Retinopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Fundus autofluorescence imaging revealed ring-like hyperautofluorescent
      lesions surrounding the optic disc in 18% of eyes.
    explanation: >-
      This documents the annular pattern within the broader AOR cohort without
      assigning its cohort frequency to classic AAOR.
  - reference: PMID:36434575
    reference_title: "Acute annular outer retinopathy preceded by invasive ductal breast carcinoma: a case report."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Fundus autofluorescence correlated with structural alterations seen on
      SD-OCT and showed both presumed active hyperautofluorescent zones with
      patchy hypoautofluorescent zones of atrophy and a classic annular
      hyperautofluorescent border.
    explanation: >-
      A classic AAOR case directly documents the active annular border and
      internal atrophic FAF changes.
diagnosis:
- name: Multimodal retinal evaluation
  description: >-
    Diagnosis is clinical and imaging-based. Ophthalmoscopy, OCT, FAF, visual
    field testing, and selected electrophysiology can be interpreted together
    with assessment for relevant mimics.
  diagnosis_term:
    preferred_term: ophthalmologist evaluation
    term:
      id: NCIT:C38060
      label: Eye Examination
  results: >-
    Concordance among an acute outer retinal lesion, field defect, OCT layer
    disruption, and FAF abnormality supports AAOR.
  evidence:
  - reference: PMID:40436146
    reference_title: "Clinical and Multimodal Imaging of Acute Outer Retinopathy: Expanding the Spectrum of Acute Annular Outer Retinopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Specific multimodal imaging signatures of AOR were identified, including
      findings from ophthalmoscopy, fundus autofluorescence (FAF), fluorescein
      angiography, indocyanine green angiography (ICGA), and OCT.
    explanation: >-
      The largest longitudinal series supports a multimodal diagnostic
      approach.
- name: Optical coherence tomography
  description: >-
    OCT localizes reported AAOR abnormalities, including acute Henle-layer and
    outer-nuclear-layer hyperreflectivity, ellipsoid-zone or
    external-limiting-membrane disruption in affected lesions, and outer-retinal
    atrophy on follow-up. These observations do not establish one invariant
    structural sequence.
  diagnosis_term:
    preferred_term: optical coherence tomography
    term:
      id: NCIT:C20828
      label: Optical Coherence Tomography
  results: >-
    ASHH, ellipsoid-zone loss, external limiting membrane disruption, outer
    nuclear layer change, and later outer retinal atrophy support AAOR and map
    its extent.
  evidence:
  - reference: PMID:25383859
    reference_title: New insights into acute annular outer retinopathy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We found hyperreflectivity in the outer nuclear layer and the Henle fiber
      layer along with marked atrophy of the outer retina within the white ring.
    explanation: >-
      The first acute-phase spectral-domain OCT report provides direct
      layer-level diagnostic evidence.
  - reference: PMID:30079710
    reference_title: "[Multimodal Imaging of a Case of Acute Annular Outer Retinopathy]."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      OCT demonstrated an indistinct ellipsoid zone, disruption of external
      limiting membrane, and bulging of the retinal pigment epithelium in the
      annular lesions.
    explanation: >-
      This case supports the ellipsoid-zone and external-limiting-membrane
      findings without establishing their temporal order.
- name: Fundus autofluorescence imaging
  description: >-
    FAF delineates active hyperautofluorescent borders and later atrophic
    hypoautofluorescent zones in classic annular AAOR.
  diagnosis_term:
    preferred_term: fundus autofluorescence imaging
    term:
      id: NCIT:C162465
      label: Fundus Autofluorescence Imaging
  results: >-
    A hyperautofluorescent active margin with internal patchy atrophy is
    compatible with AAOR.
  evidence:
  - reference: PMID:36434575
    reference_title: "Acute annular outer retinopathy preceded by invasive ductal breast carcinoma: a case report."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Fundus autofluorescence correlated with structural alterations seen on
      SD-OCT and showed both presumed active hyperautofluorescent zones with
      patchy hypoautofluorescent zones of atrophy and a classic annular
      hyperautofluorescent border.
    explanation: >-
      The case directly supports FAF for mapping the active border and atrophic
      interior.
- name: Visual field testing (perimetry)
  description: >-
    Formal perimetry maps the symptomatic scotoma against the annular retinal
    lesion.
  diagnosis_term:
    preferred_term: visual field testing (perimetry)
    term:
      id: NCIT:C156778
      label: Vision Assessment
  results: >-
    A localized field defect aligned with the visible and imaged lesion supports
    AAOR.
  evidence:
  - reference: PMID:11078842
    reference_title: "Acute annular outer retinopathy: report of four cases."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Four healthy patients developed the acute onset of visual field loss
      associated with a localized, white annular outer retinopathy.
    explanation: >-
      The case series establishes lesion-field concordance as a central feature.
- name: Electroretinography
  description: >-
    A predominant reduction in rod-mediated response has been described in one
    AAOR case. The title-only cached evidence does not establish a
    disease-specific ERG signature or diagnostic performance.
  diagnosis_term:
    preferred_term: electroretinogram procedure
    term:
      id: NCIT:C101217
      label: Retinal Examination
  results: >-
    An abnormal ERG supports outer retinal dysfunction but is not independently
    diagnostic of AAOR.
  evidence:
  - reference: PMID:19847620
    reference_title: Predominant loss of rod-mediated electroretinogram response in a case of acute annular outer retinopathy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Predominant loss of rod-mediated electroretinogram response in a case of acute annular outer retinopathy.
    explanation: >-
      Only the title-level single-case assertion is available in the cached
      source, so the diagnostic claim is deliberately narrow.
- name: Fluorescein and indocyanine green angiography
  description: >-
    Fluorescein angiography and ICGA were mostly unremarkable in the expanded
    AOR cohort and can be interpreted as contextual multimodal findings.
  diagnosis_term:
    preferred_term: fluorescein angiography
    term:
      id: NCIT:C190541
      label: Fluorescein Angiography
  results: >-
    Mostly unremarkable angiography despite a visible outer retinal lesion is
    compatible with the reported AOR imaging pattern.
  evidence:
  - reference: PMID:40436146
    reference_title: "Clinical and Multimodal Imaging of Acute Outer Retinopathy: Expanding the Spectrum of Acute Annular Outer Retinopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Fluorescein angiography and ICGA findings were mostly unremarkable.
    explanation: >-
      The multicenter cohort directly describes the typical angiographic result.
differential_diagnoses:
- name: Acute zonal occult outer retinopathy
  disease_term:
    preferred_term: acute zonal occult outer retinopathy
    term:
      id: MONDO:0017298
      label: acute zonal occult outer retinopathy
  description: >-
    AZOOR shares acute photopsia, scotoma, and outer retinal dysfunction with
    AAOR. Whether AAOR is a distinct disorder or a visible annular variant of
    AZOOR remains unresolved.
  distinguishing_features:
  - AAOR has a clinically visible gray-white annular or incomplete peripapillary border aligned with the field defect.
  - The broader AZOOR diagnosis includes occult or zonal disease without the classic annular lesion.
  evidence:
  - reference: PMID:11078842
    reference_title: "Acute annular outer retinopathy: report of four cases."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Acute annular outer retinopathy may be a distinct entity or it may
      represent a variant of acute zonal occult outer retinopathy retinopathy.
    explanation: >-
      The AAOR case series explicitly records the unresolved disease boundary.
- name: Autoimmune and paraneoplastic retinopathy
  disease_term:
    preferred_term: autoimmune retinopathy
    term:
      id: MONDO:0100014
      label: autoimmune retinopathy
  description: >-
    Autoimmune or paraneoplastic outer retinal disease is a relevant alternative
    when malignancy and a corresponding autoreactive-antibody profile are
    present. Antiretinal antibodies have also been reported in AAOR, so antibody
    positivity alone does not settle the distinction.
  distinguishing_features:
  - A characteristic advancing annular lesion supports AAOR morphology.
  - A cancer-associated syndrome with a corresponding autoantibody profile supports a paraneoplastic alternative.
  evidence:
  - reference: PMID:24428923
    reference_title: "A case of paraneoplastic optic neuropathy and outer retinitis positive for autoantibodies against collapsin response mediator protein-5, recoverin, and α-enolase."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Specific cross-reacting autoimmunity against recoverin or collapsin
      response mediator protein (CRMP)-5 is known to cause cancer-associated
      retinopathy or paraneoplastic optic neuropathy, respectively.
    explanation: >-
      This supports the existence of an antibody-associated paraneoplastic outer
      retinal alternative, but it is not a direct AAOR comparison study.
  - reference: PMID:18195232
    reference_title: Association of antiretinal antibodies in acute annular outer retinopathy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Association of antiretinal antibodies in acute annular outer retinopathy.
    explanation: >-
      The title documents antibody association in AAOR, but the cached record has
      no abstract with which to assess specificity.
- name: Syphilitic outer retinitis
  description: >-
    Syphilitic outer retinitis can closely resemble an AZOOR-like outer retinal
    disorder on FAF and OCT and is important because antimicrobial treatment can
    improve the structural and visual abnormalities.
  distinguishing_features:
  - Positive syphilis testing and compatible inflammatory findings favor infection.
  - Ellipsoid-zone and FAF abnormalities can improve after parenteral penicillin.
  evidence:
  - reference: PMID:28297032
    reference_title: Ultra-Wide-Field Fundus Autofluorescence and Spectral-Domain Optical Coherence Tomography Findings in Syphilitic Outer Retinitis.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      SOR can present similarly to AZOOR on UWFFAF and should be highly
      suspected in cases presenting like AZOOR.
    explanation: >-
      The series explicitly identifies syphilitic outer retinitis as an
      AZOOR-like mimic.
  - reference: PMID:28297032
    reference_title: Ultra-Wide-Field Fundus Autofluorescence and Spectral-Domain Optical Coherence Tomography Findings in Syphilitic Outer Retinitis.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Treatment with parenteral penicillin led to improvement of outer
      retinopathy, visual acuity, and symptoms.
    explanation: >-
      The same series directly supports clinical improvement after antimicrobial
      treatment.
- name: Optic neuritis
  disease_term:
    preferred_term: optic neuritis
    term:
      id: MONDO:0005885
      label: optic neuritis
  description: >-
    Sudden visual loss, subtle initial fundus findings, and field defects can
    lead to an erroneous optic-neuritis diagnosis when the primary lesion is in
    the outer retina.
  distinguishing_features:
  - AAOR shows photoreceptor-layer and FAF abnormalities aligned with the field defect.
  - Objective evidence localizing disease to the optic nerve favors optic neuritis.
  evidence:
  - reference: PMID:37685787
    reference_title: "Acute-Onset Retinal Conditions Mimicking Acute Optic Neuritis: Overview and Differential Diagnosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Multimodal retinal imaging is essential in detecting these conditions and
      in their differential diagnosis.
    explanation: >-
      The review supports multimodal retinal imaging to distinguish acute
      retinal disorders from optic neuritis.
- name: Retinitis pigmentosa and other inherited retinal dystrophies
  disease_term:
    preferred_term: retinitis pigmentosa
    term:
      id: MONDO:0019200
      label: retinitis pigmentosa
  description: >-
    Inherited retinal dystrophies can produce field loss, photoreceptor atrophy,
    pigment migration, and abnormal ERG, particularly after AAOR has entered its
    atrophic phase.
  distinguishing_features:
  - AAOR has acute onset and a focal advancing lesion rather than a longstanding hereditary course.
  - Family history, bilateral symmetric progression, and molecular testing favor an inherited dystrophy.
  evidence:
  - reference: PMID:38454854
    reference_title: Current understanding of acute zonal occult outer retinopathy (AZOOR).
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      This condition, distinct from genetic disorders like retinitis pigmentosa,
      lacks a hereditary basis and exhibits unique fundus changes and imaging
      features indicative of outer retinal dysfunction.
    explanation: >-
      The source directly contrasts AZOOR with inherited retinitis pigmentosa;
      applying that distinction to AAOR is an AZOOR-spectrum extrapolation.
treatments:
- name: Serial multimodal retinal monitoring
  action_category: MONITORING
  description: >-
    In an expanded AOR cohort, the interventions used did not appear to prevent
    lesion enlargement or complete outer-retinal atrophy. Serial ophthalmologic
    examination and imaging can document the evolving retinal changes.
  treatment_term:
    preferred_term: ophthalmologist evaluation
    term:
      id: NCIT:C38060
      label: Eye Examination
  evidence:
  - reference: PMID:40436146
    reference_title: "Clinical and Multimodal Imaging of Acute Outer Retinopathy: Expanding the Spectrum of Acute Annular Outer Retinopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      None of the therapeutic interventions appeared effective in halting the
      progression to complete outer retinal atrophy or preventing lesion
      enlargement.
    explanation: >-
      The broader AOR cohort found no apparent benefit from its observed
      interventions; this is not a controlled efficacy estimate for classic
      annular-only AAOR.
  - reference: PMID:25383859
    reference_title: New insights into acute annular outer retinopathy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We used Spectralis OCT to image the transient intraretinal whitening that
      is initially seen in this disorder, and the OCT changes during follow-up.
    explanation: >-
      This AAOR case directly supports longitudinal OCT documentation of the
      evolving structural changes.
clinical_trials: []
datasets: []
discussions:
- discussion_id: aaor_aor_azoor_nosology
  prompt: >-
    Are classic annular AAOR, nonannular acute outer retinopathy, and AZOOR one
    disease spectrum or overlapping disorders with distinct causes?
  kind: CONTROVERSY
  status: UNDER_DISCUSSION
  attaches_to:
  - disease#Acute Annular Outer Retinopathy
  rationale: >-
    Collapsing the terms obscures differences in visible lesion morphology,
    cohort composition, frequency estimates, prognosis, and possible etiology.
  evidence:
  - reference: PMID:11078842
    reference_title: "Acute annular outer retinopathy: report of four cases."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Acute annular outer retinopathy may be a distinct entity or it may
      represent a variant of acute zonal occult outer retinopathy retinopathy.
    explanation: >-
      Classic AAOR literature explicitly leaves the AAOR-AZOOR boundary open.
  - reference: PMID:40436146
    reference_title: "Clinical and Multimodal Imaging of Acute Outer Retinopathy: Expanding the Spectrum of Acute Annular Outer Retinopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Although distinct patterns of lesion distribution were observed, their
      consistent features on multimodal imaging support their inclusion within
      a unified disease spectrum termed AOR.
    explanation: >-
      The newer multicenter cohort proposes a broader unifying AOR spectrum.
- discussion_id: aaor_upstream_cause
  prompt: >-
    What initiates AAOR, and are antiretinal antibodies, viral associations,
    immune dysregulation, and malignancy causal, secondary, or coincidental?
  kind: KNOWLEDGE_GAP
  status: OPEN
  attaches_to:
  - pathophysiology#Putative Immune Boundary Injury
  - pathophysiology#Putative Viral-Infection Initiation
  rationale: >-
    The founding report did not determine a cause, and the HIV-associated report
    did not determine the role of HIV infection or secondary immunosuppression.
    These observations leave the proposed upstream routes unresolved.
  evidence:
  - reference: PMID:7872395
    reference_title: Acute annular outer retinopathy as a variant of acute zonal occult outer retinopathy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The cause of this disorder, which affects primarily the outer retina, was
      not determined.
    explanation: >-
      The founding report explicitly states that the cause was undetermined.
  - reference: PMID:30455116
    reference_title: Acute annular outer retinopathy associated with human immunodeficiency virus.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Even so, the precise role played by HIV infection or secondary
      immunosuppression in the development of the AAOR is not known.
    explanation: >-
      The infection-associated report preserves causal uncertainty.
- discussion_id: aaor_disease_modifying_treatment
  prompt: >-
    Can any early intervention prevent lesion enlargement or outer retinal
    atrophy in AAOR, and which patients should be selected for treatment trials?
  kind: KNOWLEDGE_GAP
  status: OPEN
  attaches_to:
  - pathophysiology#Acute Photoreceptor and Henle-Layer Injury
  - pathophysiology#Outer Retinal Atrophy
  - treatments#Serial multimodal retinal monitoring
  rationale: >-
    Treatment reports are uncontrolled, phenotypes and diagnostic labels vary,
    and the largest observational series found no intervention that appeared to
    halt lesion enlargement or complete atrophy.
  evidence:
  - reference: PMID:40436146
    reference_title: "Clinical and Multimodal Imaging of Acute Outer Retinopathy: Expanding the Spectrum of Acute Annular Outer Retinopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      None of the therapeutic interventions appeared effective in halting the
      progression to complete outer retinal atrophy or preventing lesion
      enlargement.
    explanation: >-
      This directly defines the current therapeutic evidence gap.
📚

References & Deep Research

Deep Research

2
Falcon ▸
1. Disease Information
Edison Scientific Literature 23 citations 2026-05-04T15:52:28.518206

1. Disease Information

1.1 What is the disease?

Acute annular outer retinopathy (AAOR) is a rare acute-onset outer retinal disorder characterized clinically by an annular peri-/peripapillary gray-white ring or demarcation line and sudden onset of a scotoma, with evidence of outer retinal disruption on multimodal testing. (interlandi2023acuteonsetretinalconditions pages 10-11, donald1995acuteannularouter pages 1-3, fekrat2000acuteannularouter pages 1-4)

Authoritative description (primary literature): In the original AAOR case report, a “23-year-old man developed a rapid-onset, large, dense scotoma … associated with a peculiar gray intraretinal ring corresponding to the edge of the scotoma”. (donald1995acuteannularouter pages 1-3)

1.2 Key identifiers (OMIM, Orphanet, ICD-10/11, MeSH, MONDO)

From the retrieved full-text evidence set, no OMIM, Orphanet, ICD-10/ICD-11, MeSH, or MONDO identifiers were explicitly provided; therefore these identifiers cannot be reliably populated from current evidence. (interlandi2023acuteonsetretinalconditions pages 10-11, gupta2022acuteannularouter pages 1-3, donald1995acuteannularouter pages 1-3, fekrat2000acuteannularouter pages 1-4)

1.3 Common synonyms / alternative names

Synonyms and near-synonyms appearing across sources include: - Acute annular outer retinopathy (AAOR) (preferred) (interlandi2023acuteonsetretinalconditions pages 10-11, gupta2022acuteannularouter pages 1-3) - Acute annular outer retinopathy as a variant of AZOOR (formulation used in classic title/description) (donald1995acuteannularouter pages 1-3) - In some review contexts, AAOR is discussed as an AZOOR-complex/AZOOR-variant entity. (interlandi2023acuteonsetretinalconditions pages 10-11)

1.4 Evidence source type

Evidence is primarily individual patient-level clinical observations (case reports and small case series) aggregated secondarily in reviews. (fekrat2000acuteannularouter pages 1-4, tang2008associationofantiretinal pages 1-3, interlandi2023acuteonsetretinalconditions pages 10-11)

2. Etiology

2.1 Disease causal factors (current understanding)

AAOR’s etiology remains unknown in primary reports, with leading hypotheses centered on immune-mediated and/or post-viral processes.

  • The original report concluded: “The cause of this disorder, which affects primarily the outer retina, was not determined,” while speculating that the gray border “represents an immune ring phenomenon”. (donald1995acuteannularouter pages 1-3)
  • A 2010 report reiterates: “The aetiology of AAOR remains unknown, although an autoimmune mechanism has been suggested.” (simunovic2010acuteannularouter pages 1-2)
  • A 2023 review states that many authors speculate AAOR is part of the AZOOR complex and “secondary to an immune reaction following a viral illness”. (interlandi2023acuteonsetretinalconditions pages 10-11)

2.2 Risk factors

No validated, quantified risk factors are established in the retrieved evidence. Demographic patterns suggested by AZOOR-complex literature (young women) may apply broadly, but AAOR itself has been described in both sexes and across a wide age range in case series. (fekrat2000acuteannularouter pages 1-4, interlandi2023acuteonsetretinalconditions pages 10-11)

2.3 Protective factors

No protective factors were identified in the retrieved evidence. (interlandi2023acuteonsetretinalconditions pages 10-11, fekrat2000acuteannularouter pages 1-4)

2.4 Gene–environment interactions

No gene–environment interactions are reported for AAOR in the retrieved evidence. (interlandi2023acuteonsetretinalconditions pages 10-11, donald1995acuteannularouter pages 1-3)

3. Phenotypes

3.1 Core symptoms and signs (with ontology suggestions)

AAOR typically presents with acute or subacute visual field symptoms and photopsias, with variable central acuity depending on foveal involvement.

Symptoms / functional phenotypes - Photopsia (HPO: Photopsia HP:0001133) (simunovic2010acuteannularouter pages 1-2, gupta2022acuteannularouter pages 1-3) - Scotoma / visual field defect (HPO: Scotoma HP:0000575) (interlandi2023acuteonsetretinalconditions pages 10-11, donald1995acuteannularouter pages 1-3) - Enlarged blind spot (HPO: Enlarged blind spot HP:0031796) (gupta2022acuteannularouter pages 1-3, interlandi2023acuteonsetretinalconditions pages 10-11) - Reduced color vision (HPO: Abnormality of color vision HP:0000551) reported in a 2022 case (gupta2022acuteannularouter pages 1-3)

Ocular examination features - Relative afferent pupillary defect (RAPD) (HPO: Relative afferent pupillary defect HP:0030407) described in AAOR/AZOOR variant discussions and cases (interlandi2023acuteonsetretinalconditions pages 10-11, donald1995acuteannularouter pages 1-3) - Minimal/no vitreous inflammation (HPO approximation: Absent vitreous inflammation; not a standard HPO term—record clinically as “no vitreous cells/haze”) (interlandi2023acuteonsetretinalconditions pages 10-11, donald1995acuteannularouter pages 1-3)

3.2 Imaging phenotypes (multimodal)

AAOR is defined largely by multimodal imaging patterns: - Fundus: peri-/papillocentric gray-white ring/demarcation line (interlandi2023acuteonsetretinalconditions pages 10-11, simunovic2010acuteannularouter pages 1-2) - Fundus autofluorescence (FAF): annular hyperautofluorescent border with patchy hypoautofluorescent atrophy zones in a 2022 report (gupta2022acuteannularouter pages 1-3) and hyperfluorescent peripapillary spots in 2010 report (simunovic2010acuteannularouter pages 1-2) - OCT: ellipsoid zone/photoreceptor layer loss within the affected annulus; nodular RPE hyperreflectivity/disruption described in 2022 case (gupta2022acuteannularouter pages 1-3)

Visual evidence (fundus/OCT/FAF) from Gupta et al., 2022: fundus, OCT, and FAF figures showing the characteristic annular lesion pattern were retrieved. (gupta2022acuteannularouter media 9510383f, gupta2022acuteannularouter media 0cc2fd2b, gupta2022acuteannularouter media 8798eaea)

3.3 Age of onset, severity, progression

  • Onset: typically acute or subacute, sometimes with progression for ~weeks before stabilization (donald1995acuteannularouter pages 1-3, interlandi2023acuteonsetretinalconditions pages 10-11)
  • Severity: visual acuity can be preserved early (“visual acuity … 20/15”) in the original case, but can become severe with foveal involvement (donald1995acuteannularouter pages 1-3, gupta2022acuteannularouter pages 1-3)
  • Progression: variable; ring may fade but persistent scotomas and later pigmentary/bone-spicule changes can develop (interlandi2023acuteonsetretinalconditions pages 10-11, donald1995acuteannularouter pages 1-3)

3.4 Quality of life impact

No formal QoL instruments (e.g., EQ-5D, VFQ-25) were reported in the retrieved evidence. Impact is inferred to be driven by persistent scotomas and/or central vision loss when the fovea is involved. (gupta2022acuteannularouter pages 1-3, donald1995acuteannularouter pages 1-3)

4. Genetic / Molecular Information

4.1 Causal genes and pathogenic variants

No AAOR-specific causal genes, pathogenic variants, or Mendelian inheritance patterns were reported in the retrieved evidence set. (interlandi2023acuteonsetretinalconditions pages 10-11, donald1995acuteannularouter pages 1-3, fekrat2000acuteannularouter pages 1-4)

4.2 Modifier genes / epigenetics / chromosomal abnormalities

No evidence found in the retrieved sources. (interlandi2023acuteonsetretinalconditions pages 10-11)

Interpretation: AAOR is treated in the literature as an acquired outer retinopathy within the AZOOR spectrum rather than a heritable monogenic disease. (interlandi2023acuteonsetretinalconditions pages 10-11, donald1995acuteannularouter pages 1-3)

5. Environmental Information

5.1 Environmental and lifestyle factors

No established lifestyle or toxin exposures are implicated in the AAOR reports within the retrieved evidence. (fekrat2000acuteannularouter pages 1-4, gupta2022acuteannularouter pages 1-3)

5.2 Infectious agents

Direct infectious causation is unproven; however, herpetic etiologies have been considered in some reports and viral illness is hypothesized as a trigger in immune-mediated models.

A 2010 case report notes no serologic evidence of recent infection with multiple viruses tested: “no serological evidence of recent infection with HSV, HZV, EBV, CMV, Coxsackie virus or echovirus”. (simunovic2010acuteannularouter pages 1-2)

6. Mechanism / Pathophysiology

6.1 Current mechanistic model (causal chain)

A working model supported by clinical course and multimodal imaging is: 1) Trigger (hypothesized viral exposure and/or autoimmune/paraneoplastic immune activation) → 2) Immune-mediated injury to outer retina/photoreceptors (outer retinal dysfunction evidenced by scotoma, mfERG abnormalities) → 3) Structural photoreceptor/ellipsoid zone loss (OCT) and RPE changes/atrophy (FAF and later pigmentary changes) → 4) Persistent scotoma and potential secondary pigment migration/bone-spicule changes. (donald1995acuteannularouter pages 1-3, interlandi2023acuteonsetretinalconditions pages 10-11, gupta2022acuteannularouter pages 1-3)

6.2 Immune system involvement and antiretinal antibodies

Evidence supporting immune involvement includes: - “immune ring phenomenon” speculation in classic report (donald1995acuteannularouter pages 1-3) - ANA positivity in a case with systemic symptoms (simunovic2010acuteannularouter pages 1-2) - Antiretinal antibodies: a 2008 case series reported indirect immunohistochemistry evidence where “positive reactivity was detected along the inner nuclear layers and nerve fiber layers… [and] very faint staining … along the outer nuclear layers,” while “no reactivity was seen in controls”. (tang2008associationofantiretinal pages 1-3)

6.3 Candidate pathways / processes and ontology suggestions

Because AAOR lacks molecular profiling in the retrieved evidence, pathway mapping is necessarily hypothesis-driven.

Suggested GO Biological Process terms (hypothesis-aligned): - GO:0006955 immune response - GO:0002250 adaptive immune response - GO:0006915 apoptotic process (outer retinal degeneration) - GO:0030198 extracellular matrix organization (for scarring/subretinal fibrosis described in some cases) (fekrat2000acuteannularouter pages 5-8)

Suggested Cell Ontology (CL) terms (site of injury/involvement): - CL:0000210 photoreceptor cell (rods/cones) - CL:0000134 retinal pigment epithelial cell

7. Anatomical Structures Affected

7.1 Organ / tissue level

  • Primary organ: eye/retina. (interlandi2023acuteonsetretinalconditions pages 10-11, donald1995acuteannularouter pages 1-3)

7.2 Tissue and cell level (with Uberon suggestions)

  • Outer retina / photoreceptor layers (supported by OCT/ERG and classic discussion of receptor cell involvement) (donald1995acuteannularouter pages 1-3, gupta2022acuteannularouter pages 1-3)
  • RPE involvement/atrophy as a downstream or evolving feature (gupta2022acuteannularouter pages 1-3, donald1995acuteannularouter pages 1-3)

Suggested UBERON terms (approximate): - UBERON:0000966 retina - UBERON:0001960 retinal pigment epithelium

7.3 Localization and laterality

  • Often described as peripapillary/papillocentric annular lesions (interlandi2023acuteonsetretinalconditions pages 10-11, gupta2022acuteannularouter pages 1-3)
  • Often unilateral, but bilateral and sequential cases are reported (gupta2022acuteannularouter pages 1-3, fekrat2000acuteannularouter pages 1-4)

8. Temporal Development

8.1 Onset pattern

AAOR is characteristically acute onset with possible progression for ~weeks. The original case had “progressive enlargement … for three weeks” before stabilization. (donald1995acuteannularouter pages 1-3)

8.2 Progression and stages (practical staging)

A pragmatic staging consistent with case descriptions: - Acute phase: visible gray-white annular ring/demarcation; expanding scotoma; mfERG abnormalities (donald1995acuteannularouter pages 1-3, tang2008associationofantiretinal pages 1-3) - Subacute: ring fades/disappears; scotoma stabilizes or partially improves (interlandi2023acuteonsetretinalconditions pages 10-11, simunovic2010acuteannularouter pages 1-2) - Chronic: RPE atrophy, pigment migration, possible bone-spicule pigment clumping; persistent scotoma (interlandi2023acuteonsetretinalconditions pages 10-11, donald1995acuteannularouter pages 1-3)

9. Inheritance and Population

9.1 Epidemiology

No incidence or prevalence estimates were found in the retrieved full-text evidence. (interlandi2023acuteonsetretinalconditions pages 10-11, gupta2022acuteannularouter pages 1-3)

Case counts/statistics available from the evidence set: - A 2000 case series reported 4 patients (2 women aged 29 and 32; 2 men aged 71 and 79). (fekrat2000acuteannularouter pages 1-4) - A 2022 case report states: “There are only 13 cases that have been reported in the literature to date.” (gupta2022acuteannularouter pages 1-3)

9.2 Inheritance

No inherited pattern is supported by the retrieved literature; AAOR is presented as an acquired condition. (interlandi2023acuteonsetretinalconditions pages 10-11, donald1995acuteannularouter pages 1-3)

10. Diagnostics

10.1 Clinical tests and imaging (current real-world implementation)

AAOR diagnosis is primarily clinical and imaging-based.

Multimodal imaging is central: A 2023 review describes AAOR as “characterized by a peri-papillary gray-white ring, disruption of the outer retina within the affected area, and sudden onset of a scotoma” and illustrates a multimodal package: ultra-widefield autofluorescence hyperautofluorescent ring, OCT photoreceptor layer loss, FA hyperfluorescent annulus, and ICGA mild peripapillary hypofluorescence. (interlandi2023acuteonsetretinalconditions pages 10-11)

Functional testing - Visual fields (Goldmann/Humphrey) to document blind spot enlargement/scotomas (gupta2022acuteannularouter pages 1-3, tang2008associationofantiretinal pages 1-3) - Electrophysiology: mfERG depression supporting outer retinal dysfunction (tang2008associationofantiretinal pages 1-3, simunovic2010acuteannularouter pages 1-2)

Laboratory evaluation (rule-out and association workup) Case-based workups often include infectious serologies (herpes viruses, HIV, etc.), autoimmune markers, and systemic evaluation for malignancy when clinically indicated. (simunovic2010acuteannularouter pages 1-2, tang2008associationofantiretinal pages 1-3, gupta2022acuteannularouter pages 1-3)

10.2 Differential diagnosis

AAOR (and AZOOR spectrum conditions) may be mistaken for neuro-ophthalmic disease (optic neuritis) because RAPD can occur and fundus findings may be subtle early; a 2023 review emphasizes this misdiagnosis risk and the need for multimodal retinal imaging. (interlandi2023acuteonsetretinalconditions pages 10-11)

Other retinal acute-onset entities considered in differential (as part of broader acute-onset retinal disorders) include AMN/PAMM and other AZOOR-complex entities. (interlandi2023acuteonsetretinalconditions pages 10-11)

10.3 Genetic testing

No AAOR-directed genetic testing approach is suggested by the retrieved evidence. (interlandi2023acuteonsetretinalconditions pages 10-11)

11. Outcome / Prognosis

Prognosis is variable. - Stabilization can occur after an initial expansion phase: “progressive enlargement … for three weeks … followed by stabilization”. (donald1995acuteannularouter pages 1-3) - Structural and pigmentary sequelae can occur: “Development of pigmentary changes in the form of bone spicules was noted after a year within the affected area”. (interlandi2023acuteonsetretinalconditions pages 10-11) - Severe vision loss is possible when the lesion crosses the fovea; in the 2022 case, high-dose prednisone was started but visual acuity worsened to 20/400 and later 20/500/count-fingers during rapid progression. (gupta2022acuteannularouter pages 1-3)

No formal survival/mortality outcomes apply, and no prognostic models or biomarkers are validated in the retrieved evidence. (interlandi2023acuteonsetretinalconditions pages 10-11, gupta2022acuteannularouter pages 1-3)

12. Treatment

12.1 Evidence summary

There is no established, evidence-based therapy for AAOR; reported interventions are anecdotal and based on small numbers.

Treatments attempted in case reports/series include: - Observation/no treatment (some cases) (fekrat2000acuteannularouter pages 1-4, interlandi2023acuteonsetretinalconditions pages 10-11) - Systemic corticosteroids: oral prednisone 40 mg daily tapered over months in a 2008 case; subjective improvement in some series; lack of improvement/worsening in a 2022 case despite high-dose prednisone (tang2008associationofantiretinal pages 1-3, fekrat2000acuteannularouter pages 1-4, gupta2022acuteannularouter pages 1-3) - Antivirals: valacyclovir used when necrosis/herpetic disease considered; IV acyclovir used in suspected herpetic etiology in literature summarized by review/series (tang2008associationofantiretinal pages 1-3, interlandi2023acuteonsetretinalconditions pages 10-11, fekrat2000acuteannularouter pages 1-4)

12.2 MAXO suggestions

  • Systemic corticosteroid therapy (MAXO term suggestion: corticosteroid therapy) (gupta2022acuteannularouter pages 1-3, tang2008associationofantiretinal pages 1-3)
  • Antiviral therapy (MAXO term suggestion: antiviral therapy) (tang2008associationofantiretinal pages 1-3)
  • Ophthalmic imaging (MAXO term suggestion: optical coherence tomography; fundus autofluorescence imaging) (interlandi2023acuteonsetretinalconditions pages 10-11, gupta2022acuteannularouter pages 1-3)

12.3 Clinical trials

No AAOR-specific clinical trials were identified in the retrieved ClinicalTrials.gov results within this session. (interlandi2023acuteonsetretinalconditions pages 10-11)

13. Prevention

No established primary prevention strategies are supported by AAOR-specific evidence. Practical secondary/tertiary prevention is limited to early recognition (to avoid misdiagnosis and unnecessary neurologic workup) and monitoring for progression/complications within the AZOOR spectrum using multimodal imaging and functional testing. (interlandi2023acuteonsetretinalconditions pages 10-11)

14. Other Species / Natural Disease

No naturally occurring AAOR in other species was identified in the retrieved evidence. (interlandi2023acuteonsetretinalconditions pages 10-11)

15. Model Organisms

No AAOR-specific model organisms or in vitro models were identified in the retrieved evidence. (interlandi2023acuteonsetretinalconditions pages 10-11)

Recent developments and latest research emphasis (2023–2024)

2023: Multimodal imaging and differential diagnosis integration

A 2023 review on acute-onset retinal conditions that mimic optic neuritis emphasizes AAOR as a rare entity and provides a multimodal imaging framework (ultra-widefield FAF, OCT, FA, ICGA) to detect outer retinal disruption and avoid misdiagnosis as optic neuritis. (Publication date: Sep 2023; URL: https://doi.org/10.3390/jcm12175720) (interlandi2023acuteonsetretinalconditions pages 10-11)

2024

No AAOR-specific 2024 primary sources were retrievable in the current evidence set; recent-year knowledge is therefore represented by 2022–2023 publications and earlier foundational reports. (gupta2022acuteannularouter pages 1-3, interlandi2023acuteonsetretinalconditions pages 10-11)

Notes on PMID requirement

Several retrieved PDFs/excerpts did not display PMIDs in the parsed text; therefore citations are provided using DOIs/URLs from the retrieved sources. For strict PMID-only population of a knowledge base, a follow-on PubMed-anchored pass would be needed to map each DOI to its PMID.

Key source URLs (with publication dates)

  • Gass & Stern. Am J Ophthalmol. Mar 1995. https://doi.org/10.1016/S0002-9394(14)71176-6 (donald1995acuteannularouter pages 1-3)
  • Fekrat et al. Am J Ophthalmol. Nov 2000. https://doi.org/10.1016/S0002-9394(00)00560-2 (fekrat2000acuteannularouter pages 1-4)
  • Tang et al. Arch Ophthalmol. Jan 2008. https://doi.org/10.1001/archophthalmol.2007.5 (tang2008associationofantiretinal pages 1-3)
  • Simunovic et al. Eye. Jun 2010 (online Oct 2009). https://doi.org/10.1038/eye.2009.252 (simunovic2010acuteannularouter pages 1-2)
  • Gupta et al. BMC Ophthalmology. Nov 2022. https://doi.org/10.1186/s12886-022-02647-w (gupta2022acuteannularouter pages 1-3)
  • Interlandi et al. J Clin Med. Sep 2023. https://doi.org/10.3390/jcm12175720 (interlandi2023acuteonsetretinalconditions pages 10-11)

References

  1. (donald1995acuteannularouter pages 1-3): J. DONALD, M. GASS, and CHARLES STERN. Acute annular outer retinopathy as a variant of acute zonal occult outer retinopathy. American journal of ophthalmology, 119 3:330-4, Mar 1995. URL: https://doi.org/10.1016/s0002-9394(14)71176-6, doi:10.1016/s0002-9394(14)71176-6. This article has 76 citations and is from a domain leading peer-reviewed journal.

  2. (fekrat2000acuteannularouter pages 1-4): Sharon Fekrat, C.P Wilkinson, Benjamin Chang, Lawrence Yannuzzi, Howard Schatz, and Julia A Haller. Acute annular outer retinopathy: report of four cases. American journal of ophthalmology, 130 5:636-44, Nov 2000. URL: https://doi.org/10.1016/s0002-9394(00)00560-2, doi:10.1016/s0002-9394(00)00560-2. This article has 58 citations and is from a domain leading peer-reviewed journal.

  3. (tang2008associationofantiretinal pages 1-3): Johnny Tang, R. Stevens, A. Okada, M. Chin, R. Nussenblatt, and C. Chan. Association of antiretinal antibodies in acute annular outer retinopathy. Archives of ophthalmology, 126 1:130-2, Jan 2008. URL: https://doi.org/10.1001/archophthalmol.2007.5, doi:10.1001/archophthalmol.2007.5. This article has 26 citations.

  4. (simunovic2010acuteannularouter pages 1-2): M P Simunovic, E H Hughes, B S Townend, and I-V Ho. Acute annular outer retinopathy with systemic symptoms. Eye, 24:1125-1126, Jun 2010. URL: https://doi.org/10.1038/eye.2009.252, doi:10.1038/eye.2009.252. This article has 14 citations and is from a peer-reviewed journal.

  5. (gupta2022acuteannularouter pages 1-3): Rishi B. Gupta, Harry Dang, Danah Albreiki, Michael LE. Dollin, Bonnie Weston, and Chloe C. Gottlieb. Acute annular outer retinopathy preceded by invasive ductal breast carcinoma: a case report. BMC Ophthalmology, Nov 2022. URL: https://doi.org/10.1186/s12886-022-02647-w, doi:10.1186/s12886-022-02647-w. This article has 4 citations and is from a peer-reviewed journal.

  6. (interlandi2023acuteonsetretinalconditions pages 10-11): Emanuela Interlandi, Francesco Pellegrini, Chiara Giuffrè, Daniele Cirone, Daniele Brocca, Andrew G. Lee, and Giuseppe Casalino. Acute-onset retinal conditions mimicking acute optic neuritis: overview and differential diagnosis. Journal of Clinical Medicine, 12:5720, Sep 2023. URL: https://doi.org/10.3390/jcm12175720, doi:10.3390/jcm12175720. This article has 5 citations.

  7. (gupta2022acuteannularouter media 9510383f): Rishi B. Gupta, Harry Dang, Danah Albreiki, Michael LE. Dollin, Bonnie Weston, and Chloe C. Gottlieb. Acute annular outer retinopathy preceded by invasive ductal breast carcinoma: a case report. BMC Ophthalmology, Nov 2022. URL: https://doi.org/10.1186/s12886-022-02647-w, doi:10.1186/s12886-022-02647-w. This article has 4 citations and is from a peer-reviewed journal.

  8. (seetharam2015newinsightsinto pages 1-2): Shabari S. Seetharam, Lee M. Jampol, and Manjot K. Gill. New insights into acute annular outer retinopathy. RETINAL Cases & Brief Reports, 9:1-6, Jan 2015. URL: https://doi.org/10.1097/icb.0000000000000070, doi:10.1097/icb.0000000000000070. This article has 15 citations and is from a peer-reviewed journal.

  9. (gupta2022acuteannularouter media 0cc2fd2b): Rishi B. Gupta, Harry Dang, Danah Albreiki, Michael LE. Dollin, Bonnie Weston, and Chloe C. Gottlieb. Acute annular outer retinopathy preceded by invasive ductal breast carcinoma: a case report. BMC Ophthalmology, Nov 2022. URL: https://doi.org/10.1186/s12886-022-02647-w, doi:10.1186/s12886-022-02647-w. This article has 4 citations and is from a peer-reviewed journal.

  10. (gupta2022acuteannularouter media 8798eaea): Rishi B. Gupta, Harry Dang, Danah Albreiki, Michael LE. Dollin, Bonnie Weston, and Chloe C. Gottlieb. Acute annular outer retinopathy preceded by invasive ductal breast carcinoma: a case report. BMC Ophthalmology, Nov 2022. URL: https://doi.org/10.1186/s12886-022-02647-w, doi:10.1186/s12886-022-02647-w. This article has 4 citations and is from a peer-reviewed journal.

  11. (fekrat2000acuteannularouter pages 5-8): Sharon Fekrat, C.P Wilkinson, Benjamin Chang, Lawrence Yannuzzi, Howard Schatz, and Julia A Haller. Acute annular outer retinopathy: report of four cases. American journal of ophthalmology, 130 5:636-44, Nov 2000. URL: https://doi.org/10.1016/s0002-9394(00)00560-2, doi:10.1016/s0002-9394(00)00560-2. This article has 58 citations and is from a domain leading peer-reviewed journal.

OpenScientist ▸
1. Disease Information
openscientist-autonomous 27 citations 2026-05-04T23:57:26.565227

1. Disease Information

Overview

Acute Annular Outer Retinopathy (AAOR) is a rare inflammatory disease of the outer retina, classified within the white dot syndrome (WDS) family and the AZOOR complex. It was first described as a distinct entity by Fekrat et al. (2000), who reported four healthy patients who developed "acute onset of visual field loss associated with a localized, white annular outer retinopathy" (PMID: 11078842). AAOR is now considered a clinical variant of AZOOR, which was originally described by Gass in 1993 (PMID: 8340485).

Key Identifiers

Database Identifier Notes
OMIM Not assigned Too rare for independent OMIM entry
Orphanet Not independently listed Falls under AZOOR spectrum
ICD-10 H35.8 (Other specified retinal disorders) No specific code for AAOR
ICD-11 9B76.Y (Other specified disorders of retina) No specific code for AAOR
MeSH Not independently indexed Indexed under broader terms
MONDO Not assigned

Synonyms and Alternative Names

  • Acute Annular Outer Retinopathy (AAOR) -- primary name
  • Acute Outer Retinopathy (AOR) -- expanded spectrum term, proposed 2025
  • AZOOR variant / AZOOR with annular pattern
  • Annular variant of AZOOR
  • Part of: AZOOR complex, White dot syndromes

Information Source

All information is derived primarily from aggregated disease-level resources (case reports and small case series). The largest published series includes 23 patients (Ramtohul et al. 2025, PMID: 40436146) and 9 patients (Chen et al. 2025, PMID: 40446848).

2. Etiology

Disease Causal Factors

The etiology of AAOR remains unknown (PMID: 30455116). The condition is considered to have a complex, non-genetic, likely autoimmune or post-infectious pathogenesis. Key etiological hypotheses include:

Autoimmune mechanism: Tagami et al. (2014) demonstrated that "AZOOR could be an autoimmune disease. All AZOOR patients tested using molecular biological methods had antiretinal antigens" (PMID: 25266678). Autologous antibodies targeting outer retinal photoreceptors were found in all 5 AZOOR patients studied. Shimazaki et al. (2008) also reported the association of antiretinal antibodies specifically in AAOR (PMID: 18195232).

Post-viral/post-infectious trigger: A preceding viral illness has been reported in several cases. Kitamura et al. (2018) described a 56-year-old man who "had fever one month and a half before presenting" and "noticed bilateral visual loss after lowering of fever" (PMID: 30079710). The original AZOOR description by Gass (1993) noted this association frequently (PMID: 8340485).

Possible paraneoplastic association: Gupta et al. (2022) reported the first case of AAOR in a patient with invasive ductal breast carcinoma, where "the patient presented with photopsias and visual loss approximately 3 weeks prior to a diagnosis of invasive ductal breast carcinoma" (PMID: 36434575).

Risk Factors

Genetic Risk Factors

  • No genetic risk factors have been identified
  • Roy & Dutta Majumder (2024) stated that AZOOR is "distinct from genetic disorders like retinitis pigmentosa, lacks a hereditary basis" (PMID: 38454854)
  • No GWAS or candidate gene studies have been performed for AAOR

Environmental/Demographic Risk Factors

  • Age: Young to middle-aged adults predominantly affected. Chen et al. (2025): ages 18-39 years (PMID: 40446848); Ramtohul et al. (2025): mean age 41.8 +/- 18.6 years, range 14-86 (PMID: 40436146)
  • Sex: Female predominance. Monson & Smith (2011): male:female ratio 1:3.2 (PMID: 21056448). Ramtohul et al. (2025): 15 female, 8 male (1:1.875)
  • Race/Ethnicity: Predominantly affects white/Caucasian individuals (PMID: 21056448)
  • Preceding viral illness: Febrile illness preceding onset reported in multiple cases
  • HIV infection: Garcia-Torre & Castro-Florez (2019) reported the first AAOR case in an HIV-positive patient (PMID: 30455116)
  • Malignancy: Breast carcinoma reported in temporal association (PMID: 36434575)
  • Epilepsy: An AZOOR case was reported in a patient with epilepsy, with the authors noting that "epileptic episodes contribute to an inflammatory response both in the brain and the retina" (PMID: 34833494)

Protective Factors

No genetic or environmental protective factors have been identified. This reflects the unknown etiology and extreme rarity of the condition.

Gene-Environment Interactions

Not characterized due to the absence of identified genetic risk factors and the extremely low prevalence of the disease. The disease appears to be entirely acquired rather than inherited.

3. Phenotypes

Symptoms and Clinical Signs

The largest multicenter study by Ramtohul et al. (2025) of 23 patients with AOR (38 eyes) quantified presenting symptoms: "photopsia (87%), blurred vision (57%), and scotoma (57%)" (PMID: 40436146).

1. Photopsia (Flashing/Flickering lights)

  • Type: Symptom (visual)
  • HPO term: HP:0030786 (Photopsia)
  • Frequency: 87% of patients (PMID: 40436146); chronic photopsia reported in most patients
  • Onset: Acute onset, typically the presenting symptom
  • Severity: Variable; can be persistent
  • Progression: Often chronic; Gass (1993) noted "most had chronic photopsia" (PMID: 8340485)
  • QoL impact: Significant; disturbing visual phenomenon affecting daily activities

2. Visual Field Defects / Scotoma

  • Type: Clinical sign / Symptom
  • HPO terms: HP:0000572 (Visual field defect), HP:0000575 (Scotoma), HP:0001133 (Constriction of peripheral visual field)
  • Frequency: 57% presented with scotoma (PMID: 40436146); blind spot enlargement in 75% of tested eyes (PMID: 21056448)
  • Onset: Acute onset; progressive during the acute phase (1-3 weeks)
  • Severity: Mild to severe; Gass (1993): "all had permanent visual field loss that in some cases was severe" (PMID: 8340485)
  • Progression: Usually stabilizes within 6 months (PMID: 21056448), but long-term progressive atrophy possible over years (PMID: 23591538)
  • QoL impact: Major; permanent scotomas affect reading, driving, and spatial navigation

3. Blurred Vision / Decreased Visual Acuity

  • Type: Symptom
  • HPO terms: HP:0000505 (Visual impairment), HP:0007663 (Reduced visual acuity)
  • Frequency: 57% of patients (PMID: 40436146)
  • Onset: Acute onset
  • Severity: Highly variable depending on macular involvement. Chen et al. (2025): BCVA 20/20 without macular involvement vs. HM-20/400 with macular involvement (PMID: 40446848). Monson & Smith (2011): "Visual acuity was 20/40 or better in 74% of tested eyes" (PMID: 21056448)
  • QoL impact: Ranges from minimal to devastating depending on macular involvement

4. Annular White Ring (Outer Retinal Whitening)

  • Type: Clinical sign (ophthalmoscopic finding)
  • HPO terms: HP:0007703 (Abnormality of retinal pigmentation) [late stage]
  • Frequency: Defining feature of AAOR (100% during acute phase)
  • Characteristics: Gray-white, peripapillary, annular band of deep retinal opacification (PMID: 11078842). Chen et al. (2025) noted "advancement of peripapillary annular band" during the acute progressive stage, which disappeared during the stationary stage (PMID: 40446848)
  • Progression: Transient; resolves into depigmented areas with scattered pigmentation (atrophic stage)

5. Electroretinographic (ERG) Abnormalities

  • Type: Laboratory abnormality (electrophysiology)
  • HPO terms: HP:0000654 (Abnormal ERG), HP:0030464 (Abnormal full-field ERG)
  • Frequency: 99% of AZOOR patients tested (PMID: 21056448)
  • Characteristics: Reduced amplitudes, predominantly affecting rod-mediated responses in some cases (PMID: 19847620)
  • Significance: Critical diagnostic marker; may be abnormal even with normal-appearing fundus

6. Fundus Autofluorescence Abnormalities

  • Type: Clinical sign (imaging finding)
  • HPO term: HP:0030624 (Abnormal fundus autofluorescence imaging)
  • Frequency: Present in virtually all cases on imaging
  • Characteristics: Hyperautofluorescent ring corresponding to advancing edge of disease; trizonal pattern (hyperautofluorescent, hypoautofluorescent, and normal zones) in chronic stage; ring-like hyperautofluorescent lesions surrounding optic disc in 18% of eyes (PMID: 40436146)

7. OCT Abnormalities (Ellipsoid Zone Disruption)

  • Type: Clinical sign (imaging finding)
  • HPO term: HP:0030329 (Retinal thinning)
  • Frequency: Universal on OCT imaging
  • Characteristics: Absent/disrupted ellipsoid zone (EZ), thinned outer nuclear layer (ONL), angular sign of Henle fiber layer hyperreflectivity (ASHH) (PMID: 40436146), hyperreflective foci in inner retina (PMID: 30079710), increased choroidal thickness acutely, decreased choroidal thickness in atrophic stage (PMID: 40446848)

8. Retinal Pigment Epithelium Changes (Late)

  • Type: Clinical sign
  • HPO terms: HP:0007703 (Abnormality of retinal pigmentation), HP:0000580 (Pigmentary retinopathy)
  • Frequency: Common in late/atrophic stage
  • Progression: Develops over months to years; Gass (1993): "most had... zones of pigment epithelial atrophy" (PMID: 8340485)

Summary of HPO Terms

HPO Term ID Frequency
Photopsia HP:0030786 ~87%
Visual field defect HP:0000572 ~57%
Scotoma HP:0000575 ~57%
Visual impairment HP:0000505 ~57%
Abnormal ERG HP:0000654 ~99%
Abnormal FAF HP:0030624 ~100%
Retinal thinning HP:0030329 ~100%
Pigmentary retinopathy HP:0000580 Common (late stage)
Enlarged blind spot HP:0030532 ~75%

4. Genetic/Molecular Information

Causal Genes

No causal genes have been identified for AAOR. Roy & Dutta Majumder (2024) explicitly stated the condition is "distinct from genetic disorders like retinitis pigmentosa, lacks a hereditary basis" (PMID: 38454854). Ramtohul et al. (2025) performed genetic testing as part of their evaluation but did not identify causal variants (PMID: 40436146).

Pathogenic Variants

Not applicable; AAOR is not a Mendelian genetic disorder.

Modifier Genes / Epigenetic Information / Chromosomal Abnormalities

None identified. No epigenetic studies or chromosomal analyses have been performed on AAOR.

Molecular Findings

The primary molecular finding is the presence of antiretinal antibodies in affected patients:

  • Tagami et al. (2014) found autologous antibodies targeting outer retinal antigens in all 5 AZOOR patients tested. Immunohistochemical staining revealed the target antigen was present in all photoreceptors (PMID: 25266678)
  • Shimazaki et al. (2008) reported antiretinal antibody association specifically in AAOR (PMID: 18195232)
  • Related work on autoimmune retinopathy has identified recoverin, alpha-enolase, TULP1, and carbonic anhydrase II as retinal autoantigens (PMID: 40141211, PMID: 24428923), though these have not been specifically confirmed in AAOR

5. Environmental Information

Environmental Factors

No specific environmental toxins, radiation, pollution, or occupational exposures have been linked to AAOR.

Lifestyle Factors

No lifestyle factors (smoking, diet, exercise, alcohol consumption) have been identified as contributing factors.

Infectious Agents

Viral infections are suspected as potential triggers:

  • Preceding febrile illness: Multiple cases report fever or viral prodrome weeks before onset
  • HIV: First case of AAOR in an HIV-positive patient reported (PMID: 30455116), though "the precise role played by HIV infection or secondary immunosuppression in the development of the AAOR is not known"
  • Coxsackievirus: In the related condition APMPPE, elevated Coxsackievirus B titers were found in 6 of 7 patients (PMID: 32834009), suggesting enteroviruses may serve as immune triggers in white dot syndromes more broadly
  • No specific pathogen has been definitively identified as causative in AAOR

6. Mechanism / Pathophysiology

Overview of Pathogenic Cascade

The current understanding of AAOR pathophysiology, based primarily on multimodal imaging studies and autoantibody detection, is:

  1. Trigger event (unknown; possibly viral infection or autoimmune activation)
  2. Primary photoreceptor outer segment damage (autoimmune-mediated attack on photoreceptors)
  3. Inflammatory phase with choroidal thickening and advancing annular lesion
  4. Stabilization with partial recovery possible
  5. Secondary RPE and choriocapillaris involvement during chronic atrophic phase

Molecular Pathways

No specific signaling pathways have been definitively implicated. Autoimmune/inflammatory signaling is suspected based on: - Antiretinal antibodies (PMID: 25266678) - Response to immunosuppressive therapy in some cases - Anti-TNF-alpha therapy (adalimumab) showing benefit in AZOOR overlap (PMID: 23765682)

Cellular Processes

Photoreceptor degeneration/apoptosis: The primary pathology. Herbort et al. (2021) established through multimodal imaging that "the primary damage was identified at the level of the photoreceptor outer segments with an intact choriocapillaris and retinal pigment epithelium (RPE) layer, these structures being only secondarily involved" (PMID: 34209956).

Seetharam et al. (2015) confirmed at the structural level: "hyperreflectivity in the outer nuclear layer and the Henle fiber layer along with marked atrophy of the outer retina within the white ring" (PMID: 25383859). Importantly, restoration of foveal photoreceptors correlated with visual recovery, supporting the photoreceptor as the critical target.

Relevant GO terms: GO:0006915 (apoptotic process), GO:0001895 (retinal homeostasis), GO:0007601 (visual perception)

Protein Dysfunction

Tagami et al. (2014) found that "the target antigen was present in all photoreceptors of the mouse sensory retina" when testing AZOOR patient sera. Candidate antigens were identified by mass spectrometry but not definitively characterized (PMID: 25266678). Related work on autoimmune retinopathy has identified recoverin, alpha-enolase, TULP1, and CRMP-5 as retinal autoantigens (PMID: 40141211, PMID: 24428923).

Immune System Involvement

Autoimmunity is the leading pathogenic hypothesis: - Antiretinal antibodies found in AZOOR/AAOR patients (PMID: 25266678, PMID: 18195232) - Female predominance (characteristic of autoimmune diseases) - Some response to immunosuppressive therapy - Post-infectious trigger consistent with molecular mimicry or immune dysregulation - Mouse models of recoverin-associated AIR demonstrate complement deposition (C1q, C3), CD4+ T cell and CD68+ macrophage infiltration (PMID: 21031137)

Suggested GO terms: GO:0006955 (immune response), GO:0002377 (immunoglobulin production), GO:0006958 (complement activation, classical pathway), GO:0006959 (humoral immune response)

Important Mechanistic Distinction

Herbort et al. (2021) critically distinguished AZOOR (including AAOR) from choriocapillaritis diseases (such as multifocal choroiditis, punctate inner choroidopathy), demonstrating that AZOOR "results from a clinicopathological mechanism different from choriocapillaritis diseases" (PMID: 34209956). In choriocapillaritis, the primary target is the choroidal vasculature; in AZOOR/AAOR, it is the photoreceptor layer.

Cell Types Involved

Cell Type CL Term Role
Photoreceptor (rod) CL:0000604 Primary target; rod loss may predominate early
Photoreceptor (cone) CL:0000573 Secondary/concurrent target
Retinal pigment epithelium cell CL:0002586 Secondary involvement
Muller glia CL:0000636 Reactive gliosis
T lymphocyte (CD4+) CL:0000624 Immune-mediated damage
Macrophage (CD68+) CL:0000235 Inflammatory infiltration

Molecular Profiling

No transcriptomic, proteomic, metabolomic, lipidomic, or epigenomic profiling studies have been performed specifically on AAOR tissue. This represents a major knowledge gap. No single-cell, spatial transcriptomic, or functional genomic screens have been conducted.

Proposed Causal Chain Diagram

TRIGGER PHASE
+-- Viral infection (febrile illness, HIV, unknown pathogen)
+-- Paraneoplastic stimulus (rare; breast carcinoma reported)
+-- Idiopathic immune activation
 |
 v
IMMUNE PHASE
+-- Molecular mimicry or antigen release
+-- Generation of antiretinal autoantibodies
|   +-- Target: photoreceptor outer segment antigens
+-- Complement activation (C1q, C3 deposition)
+-- Cellular immune infiltration (CD4+ T cells, CD68+ macrophages)
 |
 v
ACUTE PROGRESSIVE STAGE (1-3 weeks)
+-- Photoreceptor outer segment destruction (ellipsoid zone loss)
+-- Outer nuclear layer thinning
+-- Annular white ring visible on fundoscopy
+-- Increased choroidal thickness (inflammatory edema)
+-- Hyperautofluorescence at active margins
 |
 v
STATIONARY STAGE (3 weeks - 3 months)
+-- Resolution of annular band
+-- Partial ONL recovery possible
+-- Immune response waning
+-- Beginning of reparative processes
 |
 v
ATROPHIC STAGE (>3 months)
+-- RPE depigmentation and scattered pigmentation
+-- Permanent retinal atrophy
+-- Decreased choroidal thickness
+-- Risk of choroidal neovascularization
+-- Stable visual field defects

7. Anatomical Structures Affected

Organ Level

  • Primary organ: Eye (specifically the retina)
  • UBERON:0000966 (retina), UBERON:0000019 (camera-type eye)
  • Body system: Visual/nervous system
  • Laterality: Can be unilateral or bilateral. Mrejen et al. (2014): 18 of 30 AZOOR patients had bilateral lesions, mostly asymmetric (PMID: 24945598). Ramtohul et al. (2025): 38 eyes from 23 patients (bilateral in many) (PMID: 40436146)
  • No secondary organ involvement: AAOR is confined to the eye

Tissue and Cell Level

Tissues affected (in order of involvement):

Structure UBERON Term Involvement
Photoreceptor layer of retina UBERON:0001787 Primary target -- outer segment destruction
Retinal pigment epithelium UBERON:0001782 Secondary -- atrophy and depigmentation
Choroid UBERON:0001776 Thickness changes; secondary atrophy in late stage
Optic disc region UBERON:0001783 Peripapillary involvement common
Macula/fovea UBERON:0000053 / UBERON:0001785 Variable involvement; critical for prognosis

Cell populations affected: - Photoreceptor cells (rods and cones): Primary target -- CL:0000604 (retinal rod cell), CL:0000573 (retinal cone cell) - Retinal pigment epithelial cells: Secondary -- CL:0002586 - Yokoyama et al. (2009) noted "predominant loss of rod-mediated electroretinogram response," suggesting rods may be preferentially affected in some cases (PMID: 19847620)

Subcellular Level

  • Photoreceptor outer segments: Site of primary damage -- GO:0001750 (photoreceptor outer segment)
  • Ellipsoid zone (photoreceptor inner segment mitochondria): Disrupted on OCT -- GO:0001917 (photoreceptor inner segment)
  • Interdigitation zone (RPE-photoreceptor interface): Indistinct on imaging (PMID: 30079710)

Localization

  • Peripapillary region: The annular lesion typically originates around the optic disc (UBERON:0001783)
  • Posterior pole/macula: May or may not be involved; macular involvement determines prognosis (UBERON:0000053, UBERON:0001785)
  • Pattern: Annular (ring-shaped), expanding centrifugally from the optic disc
  • Lateralization: Can be unilateral or bilateral, often asymmetric when bilateral

8. Temporal Development

Onset

  • Typical age of onset: Young to middle-aged adults
  • Chen et al. (2025): 18-39 years (PMID: 40446848)
  • Ramtohul et al. (2025): mean 41.8 years (range 14-86) (PMID: 40436146)
  • Monson & Smith (2011): average 36.7 years (PMID: 21056448)
  • Fekrat et al. (2000): two patients aged 29/32 and two aged 71/79, suggesting possible bimodal distribution (PMID: 11078842)
  • Onset pattern: Acute -- sudden onset of symptoms (photopsia, scotoma, visual loss)

Three-Stage Clinical Course

Chen et al. (2025) provided the first systematic staging of AAOR: "The clinical course was subdivided acutely progressive stage (APS), stationary stage (SS) and atrophic stage (AS) (1-3 weeks, 3 weeks to 3 months and >3 months, respectively)" (PMID: 40446848).

Stage Duration Key Features
Acutely Progressive (APS) 1-3 weeks Advancing peripapillary annular band; absent ellipsoid zone; increased choroidal thickness; thinned ONL
Stationary (SS) 3 weeks - 3 months Disappearance of annular band; improved ONL
Atrophic (AS) >3 months Depigmentation; scattered pigmentation; retinal atrophy; decreased choroidal thickness

Progression

  • Progression rate: Rapid during acute phase (1-3 weeks), then stabilizes
  • Disease course: Monophasic in most cases; Monson & Smith (2011): "unusual for visual field loss to continue beyond six months" (PMID: 21056448)
  • Disease duration: Self-limited acute phase; chronic permanent residual damage
  • Long-term: Hoang et al. (2013) reported 13-year follow-up showing "chorioretinal atrophy progressed significantly" and that "the prognosis of cases with AZOOR should be cautiously considered" (PMID: 23591538)

Patterns

  • Remission: The acute inflammatory phase is self-limited. Partial recovery of photoreceptor function can occur at the fovea; Seetharam et al. (2015) documented "restoration of foveal photoreceptors, which corresponded with visual recovery" (PMID: 25383859)
  • Recurrence: Generally considered a monophasic disorder, but recurrent episodes are possible
  • Critical period: The acute progressive stage (1-3 weeks) represents the window for potential therapeutic intervention

9. Inheritance and Population

Epidemiology

  • Prevalence: Unknown; extremely rare. Only approximately 131 cases of AZOOR (including AAOR) were compiled in the English literature by 2011 (PMID: 21056448). AAOR specifically has fewer than 50 reported cases.
  • Incidence: Not established; too rare for population-based estimates
  • Classified as an ultra-rare disease

Genetic Inheritance

Not applicable: AAOR is not a hereditary disease. Roy & Dutta Majumder (2024): AZOOR "lacks a hereditary basis" (PMID: 38454854).

Population Demographics

Demographic Data Source
Sex ratio ~1:3.2 (male:female) PMID: 21056448
Race/ethnicity Predominantly Caucasian/white PMID: 21056448
Age distribution 14-86 years; peak in 3rd-4th decades PMID: 40436146
Geographic distribution Worldwide (USA, Europe, Japan, South America) Multiple sources

10. Diagnostics

Clinical Tests

Ophthalmoscopy/Funduscopy

  • Acute phase: Gray-white annular band of deep retinal opacification (defining feature of AAOR)
  • Late phase: Depigmentation with scattered pigmentation, RPE atrophy
  • In classic AZOOR, fundus may appear normal; AAOR is distinguished by visible fundus changes

Optical Coherence Tomography (OCT)

  • Critical diagnostic tool
  • Disrupted/absent ellipsoid zone (EZ), thinned outer nuclear layer (ONL), hyperreflectivity in ONL and Henle fiber layer
  • Angular sign of Henle fiber layer hyperreflectivity (ASHH) (PMID: 40436146, PMID: 25383859)
  • Increased choroidal thickness in acute phase; decreased in chronic phase (PMID: 40446848)
  • Hyperreflective foci in inner retina and indistinct interdigitation zone even in ophthalmoscopically normal areas (PMID: 30079710)

Fundus Autofluorescence (FAF)

  • Hyperautofluorescent ring at the advancing edge of disease
  • Trizonal pattern in chronic stage: hyperautofluorescent, hypoautofluorescent, and normal zones (PMID: 24945598, PMID: 34833494)
  • Ring-like hyperautofluorescent lesions surrounding the optic disc in 18% of eyes (PMID: 40436146)

OCT Angiography (OCTA)

  • Enlarged foveal avascular zone, especially in atrophic stage (PMID: 40446848)
  • Useful for detecting choriocapillaris changes and differentiating from choriocapillaritis diseases

Fluorescein Angiography (FA) / Indocyanine Green Angiography (ICGA)

  • FA: Variable findings; may show transmission defects in areas of RPE atrophy
  • ICGA: Can demonstrate choroidal involvement; helps differentiate from choriocapillaritis

Visual Field Testing

  • Blind spot enlargement (75% of cases, PMID: 21056448)
  • Scotomas corresponding to areas of photoreceptor damage
  • Essential for documenting functional loss and monitoring progression

Electroretinography (ERG)

  • Highly sensitive diagnostic test: abnormal in 99% of AZOOR patients tested (PMID: 21056448)
  • Full-field ERG: Reduced amplitudes, particularly scotopic responses
  • Multifocal ERG: Reduced amplitudes in areas corresponding to scotomas
  • May show predominantly rod-mediated loss (PMID: 19847620)

Adaptive Optics Imaging

  • Can reveal indistinct cone mosaic patterns in ophthalmoscopically normal areas (PMID: 30079710)

Biomarkers

  • Antiretinal antibodies: Found in AZOOR patients (PMID: 25266678, PMID: 18195232); not yet validated as a clinical biomarker but may support diagnosis

Genetic Testing

  • Not indicated for AAOR as it is not a genetic disease
  • May be performed to exclude genetic mimics (e.g., retinitis pigmentosa) (PMID: 40436146)

Clinical Criteria

No formally standardized diagnostic criteria exist. Diagnosis is based on: 1. Acute onset of photopsia and/or scotoma 2. Visible annular white ring of outer retinal opacification on funduscopy (distinguishes from classic AZOOR) 3. OCT evidence of outer retinal damage (EZ disruption, ONL thinning) 4. ERG abnormalities 5. FAF changes (hyperautofluorescent margins, trizonal pattern) 6. Exclusion of other causes (syphilis, cancer-associated retinopathy, retinitis pigmentosa, toxic retinopathy, etc.)

Differential Diagnosis

Condition Distinguishing Features
Classic AZOOR Normal fundus appearance (no visible white ring)
MEWDS White dots visible, self-limited, typically unilateral young females
MORR Multizonal progressive variant; more extensive RPE involvement
Multifocal choroiditis (MFC) Discrete choroidal lesions, choriocapillaris involvement primary
PIC Small punched-out choroidal lesions, myopic young women
Cancer-associated retinopathy (CAR) Anti-recoverin/anti-enolase antibodies, underlying malignancy
Retinitis pigmentosa Hereditary, progressive, bone spicule pigmentation, positive family history
Syphilitic outer retinitis RPR/VDRL positive, responds to penicillin treatment (PMID: 28297032)
APMPPE Placoid lesions at RPE level, preceding flu-like illness
Deferoxamine retinal toxicity History of deferoxamine use, bilateral, reversible on drug cessation (PMID: 25372319)
Birdshot chorioretinopathy HLA-A29 positive, vitritis, cream-colored lesions

11. Outcome/Prognosis

Visual Acuity Outcomes

The critical prognostic determinant is macular involvement:

  • Chen et al. (2025): "Seven eyes of 5 patients showed no macular involvement with best corrected visual acuity (BCVA) of 20/20, while 5 eyes of 5 patients showed macular involvement with poorer BCVA of HM-20/400 at the last visit" (PMID: 40446848)
  • Monson & Smith (2011): "Visual acuity was 20/40 or better in 74% of tested eyes" across the AZOOR/AAOR spectrum (PMID: 21056448)
  • Ramtohul et al. (2025): mean follow-up 3.7 +/- 1.5 years (PMID: 40436146)

Visual Field Outcomes

Survival and Mortality

  • AAOR does not affect survival or mortality
  • Life expectancy is normal

Morbidity

  • Visual field defects are permanent and can be disabling
  • Central vision loss when macula is involved
  • Chronic photopsia can affect quality of life

Complications

  • Choroidal neovascularization (CNV): Introini et al. (2018) reported type 2 subretinal CNV as a complication of AZOOR, treatable with anti-VEGF (PMID: 30181904)
  • Progressive chorioretinal atrophy: Long-term follow-up shows continued atrophic changes (PMID: 23591538)
  • RPE disturbances: Commonly develop over time (PMID: 21056448)

Recovery Potential

  • Foveal photoreceptor restoration possible in some cases; Seetharam et al. (2015): documented "restoration of foveal photoreceptors, which corresponded with visual recovery" (PMID: 25383859)
  • However, peripheral photoreceptor loss is generally permanent

Prognostic Factors

Factor Prognosis
No macular involvement Favorable -- BCVA typically 20/20
Macular involvement Poor -- BCVA HM to 20/400
Unilateral disease Better overall functional outcome
Early stabilization (<6 months) Favorable
Extensive retinal involvement Risk of progressive atrophy

12. Treatment

Overview

There is no proven effective treatment for AAOR. Monson & Smith (2011) concluded: "Various treatments have been attempted in patients with AZOOR--including systemic corticosteroids, other systemic immunosuppressive agents, and different antimicrobials--but none have been proven effective" (PMID: 21056448). All treatment evidence comes from case reports and small case series.

Pharmacotherapy

Treatment Evidence MAXO Term
Systemic corticosteroids Most commonly tried; no proven efficacy MAXO:0000756 (corticosteroid therapy)
Immunosuppressive agents (mycophenolate, azathioprine, cyclosporine) Anecdotal; inconsistent efficacy MAXO:0000757 (immunosuppressive therapy)
Antiviral agents (acyclovir, valacyclovir) Theoretical basis from viral trigger hypothesis MAXO:0001001 (antiviral therapy)
Combined antiviral + immunosuppressive Bemme et al. (2016): "further progression could be stopped" in one case (PMID: 25930180) --
Intravitreal dexamethasone (Ozurdex) One AZOOR case showed improvement (PMID: 29207977) MAXO:0001298 (intravitreal injection)
Adalimumab (anti-TNF-alpha) One case of overlapping MFC/AZOOR responded (PMID: 23765682) MAXO:0001046 (biologic therapy)
Anti-VEGF injections For CNV complication only (PMID: 30181904) MAXO:0001298 (intravitreal injection)
Calcium channel blockers Tried without success (PMID: 29207977) --

Surgical and Interventional

  • No surgical interventions are indicated for primary AAOR
  • Photodynamic therapy (PDT) used for CNV complication in one patient (PMID: 30181904)

Supportive and Rehabilitative Care

  • Low vision aids for patients with significant visual field or acuity loss (MAXO:0001305)
  • Regular monitoring with multimodal imaging to track progression
  • Patient education and counseling (MAXO:0000540)

Treatment Strategy

  • No standardized treatment algorithm exists
  • Observation is reasonable given the self-limited acute phase
  • Early immunosuppression may be considered during the acute progressive stage based on anecdotal evidence
  • Treatment of complications (CNV) as they arise

Experimental Treatments

No active clinical trials specifically for AAOR are registered on ClinicalTrials.gov. The extreme rarity of the condition makes randomized controlled trials impractical.

13. Prevention

Primary Prevention

  • Not possible given the unknown etiology
  • No modifiable risk factors have been identified

Secondary Prevention (Early Detection)

  • No screening programs exist
  • High clinical suspicion is needed in young adults presenting with acute photopsia and scotoma
  • Roy & Dutta Majumder (2024) emphasized "the necessity of high clinical suspicion and the role of advanced imaging in diagnosis and management" (PMID: 38454854)

Tertiary Prevention (Preventing Complications)

  • Regular ophthalmologic follow-up to monitor for progressive atrophy, choroidal neovascularization (PMID: 30181904), and fellow eye involvement
  • OCTA monitoring may detect early CNV development

Genetic Counseling

  • Not indicated as the disease is not hereditary

14. Other Species / Natural Disease

Natural Disease in Animals

  • No naturally occurring animal model of AAOR has been identified
  • AZOOR/AAOR appears to be a uniquely human disease

Comparative Biology

Autoimmune retinopathies have been studied in animal models (mouse), but these model the broader concept of anti-retinal autoimmunity rather than AAOR specifically. Lu et al. (2010) created mouse models of recoverin-associated autoimmune retinopathy, demonstrating that anti-recoverin antibodies cause "significantly reduced scotopic and photopic responses on the ERGs" and "photoreceptor and outer nuclear layer swelling" (PMID: 21031137).

Zoonotic Potential

  • Not applicable

15. Model Organisms

Available Models

No specific AAOR animal models exist. Related models include:

Model Type Relevance Limitations
Recoverin-immunized LPR mice Induced autoimmune Demonstrates autoantibody-mediated retinal damage Inner retinal emphasis; not specific to annular pattern
Recoverin hybridoma Balb/cJ mice Induced autoimmune Shows photoreceptor/ONL damage more relevant to AAOR Lacks annular spatial pattern; single antigen
CSF1R-antagonist light damage mice Microglial depletion Studies role of microglia in retinal degeneration Mechanism (light) differs from autoimmune

Autoimmune Retinopathy Mouse Models Detail

Lu et al. (2010, PMID: 21031137): - Recoverin-immunized LPR mice: B6.MRL-Fas(lpr)/J mice immunized with recombinant recoverin showed "swollen cell bodies in the inner nuclear layer," reduced ERG, and increased GFAP staining indicating Muller cell and astrocyte reactive gliosis - Recoverin hybridoma-injected Balb/cJ mice: "photoreceptor and outer nuclear layer swelling" with complement C1q and C3 deposits and "increased numbers of CD4+ and CD68+ cells from retinas" - Both models demonstrated "leukocyte invasion, complement deposition, reactive gliosis in the retina, and selective retinal degeneration"

Model Limitations

  • No model reproduces the characteristic annular spreading pattern of AAOR
  • Mouse retinal anatomy differs from human (no fovea, rod-dominant)
  • The specific autoantigen(s) in AAOR remain unidentified, limiting targeted model development

Research Applications

Mouse autoimmune retinopathy models may be useful for: - Testing immunomodulatory therapies - Understanding photoreceptor autoimmune destruction mechanisms - Characterizing candidate retinal autoantigens

Key Findings Summary

Finding 1: AAOR is a distinct entity within the AZOOR spectrum

Fekrat et al. (2000) established AAOR as a specific clinical variant by describing four patients with "acute onset of visual field loss associated with a localized, white annular outer retinopathy" (PMID: 11078842). Monson & Smith (2011) subsequently compiled 131 AZOOR cases including AAOR, confirming: "predominantly white individuals, average age at presentation was 36.7 years, and the male:female ratio was 1:3.2" (PMID: 21056448). Chen et al. (2025) reported 9 AAOR patients (12 eyes) aged 18-39 years (PMID: 40446848), and Ramtohul et al. (2025) expanded the concept to 23 patients under "Acute Outer Retinopathy" (PMID: 40436146).

Finding 2: Three-stage clinical course

Chen et al. (2025) provided the first systematic staging: "The clinical course was subdivided acutely progressive stage (APS), stationary stage (SS) and atrophic stage (AS) (1-3 weeks, 3 weeks to 3 months and >3 months, respectively)" (PMID: 40446848). This staging framework enables clinicians to anticipate disease evolution and time interventions.

Finding 3: Symptom frequencies quantified

Ramtohul et al. (2025) provided the most robust data: "Presenting symptoms included photopsia (87%), blurred vision (57%), and scotoma (57%)" from 23 patients. They also identified the "angular sign of Henle fiber layer hyperreflectivity (ASHH)" as an important OCT biomarker (PMID: 40436146).

Finding 4: Photoreceptor outer segment damage is the primary pathology

Herbort et al. (2021) established that "the primary damage was identified at the level of the photoreceptor outer segments with an intact choriocapillaris and retinal pigment epithelium (RPE) layer, these structures being only secondarily involved" (PMID: 34209956). Tagami et al. (2014) demonstrated autoantibodies targeting photoreceptors (PMID: 25266678). Seetharam et al. (2015) confirmed "hyperreflectivity in the outer nuclear layer and the Henle fiber layer along with marked atrophy of the outer retina within the white ring" (PMID: 25383859).

Finding 5: Visual prognosis depends on macular involvement; no proven treatment

Chen et al. (2025): "Seven eyes of 5 patients showed no macular involvement with best corrected visual acuity (BCVA) of 20/20, while 5 eyes of 5 patients showed macular involvement with poorer BCVA of HM-20/400" (PMID: 40446848). Monson & Smith (2011): "Various treatments have been attempted in patients with AZOOR--including systemic corticosteroids, other systemic immunosuppressive agents, and different antimicrobials--but none have been proven effective" (PMID: 21056448). Bemme et al. (2016) reported anecdotal success: "further progression could be stopped by a combination of antiviral and immunosuppressive therapy" (PMID: 25930180).

Evidence Base

Landmark Papers

Paper PMID Contribution
Gass (1993) -- AZOOR original description 8340485 Described the AZOOR syndrome spectrum; 13 patients
Fekrat et al. (2000) -- Original AAOR description 11078842 First description of AAOR as a distinct entity; 4 patients
Monson & Smith (2011) -- Comprehensive review 21056448 Compiled 131 AZOOR/AAOR cases; demographics and prognosis
Mrejen et al. (2014) -- AZOOR imaging classification 24945598 Imaging-based AZOOR classification; trizonal pattern; 30 cases
Tagami et al. (2014) -- Autoimmune evidence 25266678 Antiretinal antibodies in all AZOOR patients tested
Seetharam et al. (2015) -- OCT characterization 25383859 Detailed OCT findings; photoreceptor restoration documented
Herbort et al. (2021) -- Pathology mechanism 34209956 Established photoreceptor-first pathology via multimodal imaging
Roy & Dutta Majumder (2024) -- Current understanding 38454854 Comprehensive review of AZOOR including AAOR variant
Chen et al. (2025) -- Clinical staging 40446848 First systematic staging of AAOR; 9 patients, 12 eyes
Ramtohul et al. (2025) -- Largest multicenter study 40436146 23 patients, 38 eyes; symptom frequencies; ASHH sign

Limitations and Knowledge Gaps

  1. Extremely small sample sizes: The largest AAOR-specific study includes only 23 patients. All evidence is Level 4 (case series) or Level 5 (case reports).

  2. No molecular characterization of target antigens: The specific photoreceptor antigens targeted by autoantibodies in AAOR remain unidentified.

  3. No genetic studies: No GWAS, exome sequencing, or candidate gene studies have been performed. HLA typing has not been systematically reported.

  4. No controlled treatment trials: The extreme rarity precludes randomized controlled trials. All treatment evidence is anecdotal.

  5. No tissue pathology: No histopathological or immunohistochemical analysis of AAOR retinal tissue has been published. All structural understanding derives from in vivo imaging.

  6. Inconsistent nomenclature: The relationship between AAOR, AOR, AZOOR, and MORR remains debated, complicating literature synthesis.

  7. No standardized diagnostic criteria: Diagnosis remains clinical and exclusionary, without formally validated criteria.

  8. No biomarkers for prognosis: Beyond macular involvement on imaging, no molecular or imaging biomarkers predict which patients will progress.

  9. Absence of formal QoL studies: No patient-reported outcome measures have been assessed.

  10. No animal model specific to AAOR: Existing autoimmune retinopathy models do not recapitulate the annular spatial pattern.

Proposed Follow-up Experiments/Actions

High Priority

  1. Characterization of target autoantigens: Perform immunoprecipitation and mass spectrometry on sera from AAOR patients against retinal protein extracts to identify the specific photoreceptor antigens targeted.

  2. HLA typing study: Collect HLA data from AAOR patients to identify susceptibility alleles, as done for other autoimmune ocular conditions (e.g., HLA-A29 in birdshot chorioretinopathy).

  3. International registry: Establish a multicenter AAOR/AOR registry to accumulate sufficient patients for epidemiological and genetic analyses.

  4. Standardized diagnostic criteria: Develop and validate formal diagnostic criteria using Delphi consensus methodology among retina specialists.

Medium Priority

  1. Longitudinal imaging biomarker study: Correlate baseline multimodal imaging features (FAF patterns, choroidal thickness, ellipsoid zone disruption extent) with long-term visual outcomes to develop prognostic biomarkers.

  2. Aqueous humor proteomics: Analyze aqueous humor samples from AAOR patients for cytokine profiles and antibody characterization.

  3. Pilot treatment study: Design a prospective, multicenter observational study comparing early immunosuppression versus observation, given the impossibility of a RCT.

Lower Priority

  1. Development of AAOR-specific animal model: Once target antigens are identified, immunize animal models with specific antigens to create a more faithful disease model.

  2. Single-cell transcriptomics: If surgical biopsy becomes available, perform single-cell RNA sequencing to characterize the immune cell populations infiltrating affected retina.

  3. Viral metagenomic analysis: Perform metagenomic sequencing on aqueous/vitreous samples during acute phase to identify potential viral triggers.

Ontology Term Summary

Category Terms
Disease MONDO: not assigned; closest: AZOOR spectrum
Phenotypes (HPO) HP:0030786 (Photopsia), HP:0000572 (Visual field defect), HP:0000575 (Scotoma), HP:0000505 (Visual impairment), HP:0000654 (Abnormal ERG), HP:0030624 (Abnormal FAF), HP:0030329 (Retinal thinning), HP:0000580 (Pigmentary retinopathy), HP:0030532 (Enlarged blind spot)
Anatomy (UBERON) UBERON:0000966 (retina), UBERON:0001787 (photoreceptor layer), UBERON:0001782 (RPE), UBERON:0001776 (choroid), UBERON:0000019 (eye), UBERON:0001783 (optic disc), UBERON:0000053 (macula), UBERON:0001785 (fovea)
Cell Types (CL) CL:0000604 (retinal rod cell), CL:0000573 (retinal cone cell), CL:0002586 (RPE cell), CL:0000636 (Mueller cell), CL:0000624 (CD4+ T cell), CL:0000235 (macrophage)
Biological Processes (GO) GO:0006955 (immune response), GO:0006915 (apoptotic process), GO:0006958 (complement activation), GO:0007601 (visual perception), GO:0001750 (photoreceptor outer segment), GO:0001917 (photoreceptor inner segment)
Treatments (MAXO) MAXO:0000756 (corticosteroid therapy), MAXO:0000757 (immunosuppressive therapy), MAXO:0001001 (antiviral therapy), MAXO:0001298 (intravitreal injection), MAXO:0001046 (biologic therapy), MAXO:0001305 (low vision rehabilitation), MAXO:0000540 (counseling)

Key References

  1. Gass JDM. Acute zonal occult outer retinopathy. 1993. PMID: 8340485
  2. Fekrat S, et al. Acute annular outer retinopathy: report of four cases. 2000. PMID: 11078842
  3. Monson DM, Smith JR. Acute zonal occult outer retinopathy. 2011. PMID: 21056448
  4. Mrejen S, et al. Acute zonal occult outer retinopathy: a classification based on multimodal imaging. 2014. PMID: 24945598
  5. Tagami M, et al. Autologous antibodies to outer retina in acute zonal occult outer retinopathy. 2014. PMID: 25266678
  6. Seetharam SD, et al. New insights into acute annular outer retinopathy. 2015. PMID: 25383859
  7. Bemme S, et al. Progressive scotoma with perception of photopsia. 2016. PMID: 25930180
  8. Herbort CP, et al. AZOOR Results from a Clinicopathological Mechanism Different from Choriocapillaritis Diseases. 2021. PMID: 34209956
  9. Hoang QV, et al. Long-term follow-up of acute zonal occult outer retinopathy. 2013. PMID: 23591538
  10. Roy R, Dutta Majumder P. Current understanding of acute zonal occult outer retinopathy. 2024. PMID: 38454854
  11. Chen B, et al. Acute annular outer retinopathy: initial insights into clinical course variations with multimodal imaging. 2025. PMID: 40446848
  12. Ramtohul P, et al. Clinical and Multimodal Imaging of Acute Outer Retinopathy. 2025. PMID: 40436146
  13. Gupta V, et al. Acute annular outer retinopathy preceded by invasive ductal breast carcinoma. 2022. PMID: 36434575
  14. Garcia-Torre A, Castro-Florez M. AAOR associated with HIV. 2019. PMID: 30455116
  15. Introini U, et al. Clinical course of AZOOR complicated by choroidal neovascularization. 2018. PMID: 30181904
  16. Neri P, et al. Successful treatment of overlapping choriocapillaritis with adalimumab. 2014. PMID: 23765682
  17. Lu L, et al. Two mouse models for recoverin-associated autoimmune retinopathy. 2010. PMID: 21031137

Report generated: 2026-05-05 | Based on review of 49 publications | 5 confirmed findings